Difficult or labored breathing.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.
The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.
A disorder characterized by sudden attacks of respiratory distress in at rest patients with HEART FAILURE and PULMONARY EDEMA. It usually occurs at night after several hours of sleep in a reclining position. Patients awaken with a feeling of suffocation, coughing, a cold sweat, and TACHYCARDIA. When there is significant WHEEZING, it is called cardiac asthma.
Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
Measurement of volume of air inhaled or exhaled by the lung.
The volume of air that is exhaled by a maximal expiration following a maximal inspiration.
Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.
These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Any hindrance to the passage of air into and out of the lungs.
The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
Therapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Analogs or derivatives of scopolamine.
Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed)
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Pathological processes involving any part of the LUNG.
Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.
The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Disease having a short and relatively severe course.
The act of BREATHING in.
RESPIRATORY MUSCLE contraction during INHALATION. The work is accomplished in three phases: LUNG COMPLIANCE work, that required to expand the LUNGS against its elastic forces; tissue resistance work, that required to overcome the viscosity of the lung and chest wall structures; and AIRWAY RESISTANCE work, that required to overcome airway resistance during the movement of air into the lungs. Work of breathing does not refer to expiration, which is entirely a passive process caused by elastic recoil of the lung and chest cage. (Guyton, Textbook of Medical Physiology, 8th ed, p406)
Endoscopic examination, therapy or surgery of the bronchi.
A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.
Measure of the maximum amount of air that can be breathed in and blown out over a sustained interval such as 15 or 20 seconds. Common abbreviations are MVV and MBC.
The amount of a gas taken up, by the pulmonary capillary blood from the alveolar gas, per minute per unit of average pressure of the gradient of the gas across the BLOOD-AIR BARRIER.
The volume of air remaining in the LUNGS at the end of a maximal expiration. Common abbreviation is RV.
Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.
Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed)
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.
Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration (= OXYGEN CONSUMPTION) or cell respiration (= CELL RESPIRATION).
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
An activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking.
The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: VITAL CAPACITY plus RESIDUAL VOLUME; INSPIRATORY CAPACITY plus FUNCTIONAL RESIDUAL CAPACITY; TIDAL VOLUME plus INSPIRATORY RESERVE VOLUME plus functional residual capacity; or tidal volume plus inspiratory reserve volume plus EXPIRATORY RESERVE VOLUME plus residual volume.
Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma.
Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds.
The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is ERV.
An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a "pneumonia-like" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.
Pressure, burning, or numbness in the chest.

Long-term recovery of diaphragm strength in neuralgic amyotrophy. (1/1741)

Diaphragm paralysis is a recognized complication of neuralgic amyotrophy that causes severe dyspnoea. Although recovery of strength in the arm muscles, when affected, is common, there are little data on recovery of diaphragm function. This study, therefore, re-assessed diaphragm strength in cases of bilateral diaphragm paralysis due to neuralgic amyotrophy that had previously been diagnosed at the authors institutions. Fourteen patients were recalled between 2 and 11 yrs after the original diagnosis. Respiratory muscle and diaphragm strength were measured by volitional manoeuvres as maximal inspiratory pressure and sniff transdiaphragmatic pressure. Cervical magnetic phrenic nerve stimulation was used to give a nonvolitional measure of diaphragm strength: twitch transdiaphragmatic pressure. Only two patients remained severely breathless. Ten of the 14 patients had evidence of some recovery of diaphragm strength, in seven cases to within 50% of the lower limit of normal. The rate of recovery was variable: one patient had some recovery after 2 yrs, and the rest took 3 yrs or more. In conclusion, in most patients with diaphragm paralysis due to neuralgic amyotrophy, some recovery of the diaphragm strength occurs, but the rate of recovery may be slow.  (+info)

Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind study of peak flow changes prior to emergency department visits. (2/1741)

The aim of this study was to look at changes in peak expiratory flow rates (PEFR) prior to emergency department visits for decompensated chronic obstructive pulmonary disease (COPD). It was designed as a prospective, double-blind study at the Albuquerque Veterans Affairs Medical Center. Twelve patients with an irreversible component of airflow obstruction on pulmonary function tests were assessed. At entry, all subjects were instructed in the use of a mini-Wright peak flow meter with electronic data storage. They then entered a 6-month monitoring phase in which they recorded PEFR twice daily, before and after bronchodilators. The meter displays were disabled so that the patients and their physicians were blinded to all values. Medical care was provided in the customary manner. Patients were considered to have respiratory decompensation if they required treatment for airflow obstruction in the Emergency Department (ED) and no other causes of dyspnea could be identified. Simple linear regression was used to model changes in PEFR over time. The 12 subjects had 22 episodes of respiratory decompensation during 1741 patient-days of observation. Two episodes could not be analysed because of missing values. Ten episodes in seven subjects were characterized by a significant linear decline in at least one peak flow parameter prior to presentation. The mean rates of change for the four daily parameters varied from 0.22% to 0.27% predicted per day (or 1.19 to 1.44 1 min-1 day-1). The average decrement in these parameters ranged from 30.0 to 33.8 1 min-1 (or 18.6%-25.9% of their baseline values). No temporal trends were found for the 10 episodes occurring in the other five subjects. We concluded that respiratory decompensation is characterized by a gradual decline in PEFR in about half of cases. Future studies should be done to elucidate the mechanisms of respiratory distress in the other cases.  (+info)

Early occurrence of respiratory muscle deoxygenation assessed by near-infrared spectroscopy during leg exercise in patients with chronic heart failure. (3/1741)

The mechanisms of respiratory muscle deoxygenation during incremental leg exercise with expired gas analysis were investigated in 29 patients with chronic heart failure and 21 normal subjects. The deoxygenation and blood volume of the respiratory muscle and exercising leg muscle were assessed by near-infrared spectroscopy (NIRS). To evaluate the influence of the leg exercise on the blood volume of the respiratory muscle, 10 normal subjects also underwent a hyperventilation test with NIRS. The respiratory muscle deoxygenation point (RDP), at which oxygenated hemoglobin starts to decrease, was observed in both groups during exercise. The oxygen consumption (VO2) and the minute ventilation at the RDP in the patients was lower (p<0.01). At the same VO2, the respiratory rate was higher in patients (p<0.01). During exercise, the blood volume of the leg muscle increased, while that of the respiratory muscle decreased. During a hyperventilation test, the minute ventilation was higher than that of the RDP during exercise, the blood volume of the respiratory muscle did not decrease, and the RDP was not detectable. In conclusion, a limited ability to increase perfusion of respiratory muscles during exercise combined with the greater work of breathing results in early respiratory muscle deoxygenation in patients with chronic heart failure.  (+info)

A case of eosinophilic myocarditis complicated by Kimura's disease (eosinophilic hyperplastic lymphogranuloma) and erythroderma. (4/1741)

This report describes a patient with eosinophilic myocarditis complicated by Kimura's disease (eosinophilic hyperplastic lymphogranuloma) and erythroderma. A 50-year-old man presented with a complaint of precordial pain. However, the only abnormal finding on examinatioin was eosinophilia (1617 eosinophils/microl). Three years later, the patient developed chronic eczema, and was diagnosed with erythroderma posteczematosa. One year later, a tumor was detected in the right auricule, and a diagnosis of Kimura's disease was made, based on the biopsy findings. The patient developed progressive dyspnea 6 months later and was found to have cardiomegaly and a depressed left ventricular ejection fraction (17%). A diagnosis of eosinophilic myocarditis was made based on the results of a right ventricular endomyocardial biopsy. The eosinophilic myocarditis and erythrodrema were treated with steroids with improvement of both the eosinophilia and left ventricular function.  (+info)

Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. (5/1741)

BACKGROUND: The CABG Patch trial compared prophylactic implantable cardiac-defibrillator (ICD) implantation with no antiarrhythmic therapy in coronary bypass surgery patients who had a left ventricular ejection fraction <0.36 and an abnormal signal-averaged ECG. There were 102 deaths among the 446 ICD group patients and 96 deaths among the 454 control group patients, a hazard ratio of 1.07 (P=0.63). The mechanisms of death were classified, and hypotheses were tested about the effects of ICD therapy on arrhythmic and nonarrhythmic cardiac deaths in the CABG Patch Trial and the Multicenter Automatic Defibrillator Implantation Trial (MADIT). METHODS AND RESULTS: The 198 deaths in the trial were reviewed by an independent Events Committee and classified by the method of Hinkle and Thaler. Only 54 deaths (27%) occurred out of hospital; 145 deaths (73%) were witnessed. Seventy-nine (82%) of the 96 deaths in the control group and 76 (75%) of the 102 deaths in the ICD group were due to cardiac causes. Cumulative arrhythmic mortality at 42 months was 6.9% in the control group and 4.0% in the ICD group (P=0. 057). Cumulative nonarrhythmic cardiac mortality at 42 months was 12. 4% in the control group and 13.0% in the ICD group (P=0.275). Death due to pump failure was significantly associated with death >1 hour from the onset of symptoms, dyspnea within 7 days of death, and overt heart failure within 7 days of death. CONCLUSIONS: In the CABG Patch Trial, ICD therapy reduced arrhythmic death 45% without significant effect on nonarrhythmic deaths. Because 71% of the deaths were nonarrhythmic, total mortality was not significantly reduced.  (+info)

Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. (6/1741)

OBJECTIVES: To assess the impact of myocardial infarction on quality of life in four year survivors compared to data from "community norms", and to determine factors associated with a poor quality of life. DESIGN: Cohort study based on the Nottingham heart attack register. SETTING: Two district general hospitals serving a defined urban/rural population. SUBJECTS: All patients admitted with acute myocardial infarction during 1992 and alive at a median of four years. MAIN OUTCOME MEASURES: Short form 36 (SF 36) domain and overall scores. RESULTS: Of 900 patients with an acute myocardial infarction in 1992, there were 476 patients alive and capable of responding to a questionnaire in 1997. The response rate was 424 (89. 1%). Compared to age and sex adjusted normative data, patients aged under 65 years exhibited impairment in all eight domains, the largest differences being in physical functioning (mean difference 20 points), role physical (mean difference 23 points), and general health (mean difference 19 points). In patients over 65 years mean domain scores were similar to community norms. Multiple regression analysis revealed that impaired quality of life was closely associated with inability to return to work through ill health, a need for coronary revascularisation, the use of anxiolytics, hypnotics or inhalers, the need for two or more angina drugs, a frequency of chest pain one or more times per week, and a Rose dyspnoea score of >/= 2. CONCLUSIONS: The SF 36 provides valuable additional information for the practising clinician. Compared to community norms the greatest impact on quality of life is seen in patients of working age. Impaired quality of life was reported by patients unfit for work, those with angina and dyspnoea, patients with coexistent lung disease, and those with anxiety and sleep disturbances. Improving quality of life after myocardial infarction remains a challenge for physicians.  (+info)

Syphilitic aortic regurgitation. An appraisal of surgical treatment. (7/1741)

During the 10 years from 1964 to 1973, fifteen patients with severe syphilitic aortic regurgitation were treated surgically at the National Heart Hospital. In thirteen the valve was replaced and in two it was repaired. In addition four had replacement of an aneurysmal ascending aorta with a Dacron graft and seven some form of plastic repair to the coronary ostia. Three patients died within 1 month of surgery and a further six during the follow-up period which varied from 1 to 55 months (mean 25-5). The six survivors have been followed-up for an average of 33 months. Factors contributing to this high mortality were analysed and it was found that the mean duration of effort dyspnoea was 22 months in the survivors compared with 48 months in those who had died. Similarly the average duration of nocturnal dyspnoea was 4 months in the survivors compared with a mean of 8 months in those who had died. Only six out of the fifteen patients had angina; this was present in two of the survivors and in four of the fatalities. The pulse pressure, heart size, and haemodynamic findings were similar in the two groups. The prognostic value of an elevated erythocyte sedimentation rate was also examined. It was concluded that preoperative investigations should include aortography, coronary arteriography, an assessment of left ventricular function, and whenever possible myocardial biopsy. These data were interpreted as suggesting that patients should be referred for surgery at an earlier stage in the disease--certainly before the onset of cardiac failure and--and that if this more aggresive attitude was adopted, as it has been in non-syphilitic cases of aortic valve disease, the present high mortality in this group would be reduced.  (+info)

Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. (8/1741)

OBJECTIVE: To evaluate the effectiveness of nursing intervention for breathlessness in patients with lung cancer. DESIGN: Patients diagnosed with lung cancer participated in a multicentre randomised controlled trial where they either attended a nursing clinic offering intervention for their breathlessness or received best supportive care. The intervention consisted of a range of strategies combining breathing control, activity pacing, relaxation techniques, and psychosocial support. Best supportive care involved receiving standard management and treatment available for breathlessness, and breathing assessments. Participants completed a range of self assessment questionnaires at baseline, 4 weeks, and 8 weeks. SETTING: Nursing clinics within 6 hospital settings in the United Kingdom. PARTICIPANTS: 119 patients diagnosed with small cell or non-small cell lung cancer or with mesothelioma who had completed first line treatment for their disease and reported breathlessness. OUTCOME MEASURES: Visual analogue scales measuring distress due to breathlessness, breathlessness at best and worst, WHO performance status scale, hospital anxiety and depression scale, and Rotterdam symptom checklist. RESULTS: The intervention group improved significantly at 8 weeks in 5 of the 11 items assessed: breathlessness at best, WHO performance status, levels of depression, and two Rotterdam symptom checklist measures (physical symptom distress and breathlessness) and showed slight improvement in 3 of the remaining 6 items. CONCLUSION: Most patients who completed the study had a poor prognosis, and breathlessness was typically a symptom of their deteriorating condition. Patients who attended nursing clinics and received the breathlessness intervention experienced improvements in breathlessness, performance status, and physical and emotional states relative to control patients.  (+info)

2020-1-7 · RESULTS: Of the 97 subjects, 7 with COPD did not wear the N95 for the entire test duration. This mask-failure group showed higher British modified Medical Research Council dyspnea scale scores and lower FEV 1 percent of predicted values than did the successful mask use group. A modified Medical Research Council dyspnea scale score ≥ 3 (odds ratio 167, 95% CI 8.4 to ,999.9; P = .008) or a FEV ... ...
Chronic dyspnea is shortness of breath that lasts more than one month. The perception of dyspnea varies based on behavioral and physiologic responses. Dyspnea that is greater than expected with the degree of exertion is a symptom of disease. Most cases of dyspnea result from asthma, heart failure and myocardial ischemia, chronic obstructive pulmonary disease, interstitial lung disease, pneumonia, or psychogenic disorders. The etiology of dyspnea is multifactorial in about one-third of patients. The clinical presentation alone is adequate to make a diagnosis in 66 percent of patients with dyspnea. Patients descriptions of the sensation of dyspnea may be helpful, but associated symptoms and risk factors, such as smoking, chemical exposures, and medication use, should also be considered. Examination findings (e.g., jugular venous distention, decreased breath sounds or wheezing, pleural rub, clubbing) may be helpful in making the diagnosis. Initial testing in patients with chronic dyspnea includes chest
Total Transient Dyspnea Index (TDI) is part of the BDI/TDI questionnaire where participants indicated whether they improved or deteriorated since their Baseline Dyspnea Index (BDI). The BDI and TDI each had 3 domains: activities, tasks, and effort. BDI domains were rated from 0 (very severe) to 4 (none) and the rates summed for the total BDI score ranging from 0 to 12; the lower the score the worse the severity of dyspnea. TDI domains were rated from -6 (major deterioration) to 6 (major improvement) and the rates summed for the total TDI score ranging from -18 to 18. However, to ensure comparability with the TDI paper version, all TDI values were divided by 2 before the analysis. If data was missing or insufficient for any one of the domains a BDI/TDI was calculated. BDI = Baseline Dyspnea Index taken 75 min prior to the first dose in each treatment period. TDI = Transition Dyspnea Index taken after 6 weeks of treatment 75 min prior to the last dose in each treatment period ...
Methods: COPD patients (n=137) underwent pulmonary and cardiac system examination and pulmonary function tests (PFTs) before PR. Chest X-rays, arterial blood gases, body mass index, quality of life (QOL) questionnaires, anxiety and depression scores, and Modified Medical Research Council dyspnea scale (MMRC) scores were evaluated in all patients. A 6-min walk test was performed to determine the exercise capacity of the patients. All patients underwent an 8-week outpatient PR program. The patients were reevaluated at the end of 8th week in terms of all parameters ...
BACKGROUND: Exertional dyspnea is the most prominent and disabling feature in idiopathic pulmonary fibrosis (IPF). The Medical Research Chronic (MRC) chronic dyspnea score as well as physiological measurements obtained during cardiopulmonary exercise testing (CPET) and the 6-minute walk test (6MWT) are shown to provide information on the severity and survival of disease.. METHODS: We prospectively recruited IPF patients and examined the relationship between the MRC score and either CPET or 6MWT parameters known to reflect physiologic derangements limiting exercise capacity in IPF patients. RESULTS: Twenty-five patients with IPF were included in the study. Significant correlations were found between the MRC score and the distance (r = -.781, p , 0.001), the SPO2 at the initiation and the end (r = -.542, p = 0.005 and r = -.713, p , 0.001 respectively) and the desaturation index (r = .634, p = 0.001) for the 6MWT; the MRC score and VO2 peak/kg (r = -.731, p , 0.001), SPO2 at peak exercise (r = -. ...
Dyspnoea is a cardinal symptom for cardiorespiratory diseases. No study has assessed worldwide variation in dyspnoea prevalence or predictors of dyspnoea. We used cross-sectional data from population-based samples in 15 countries of the Burden of Obstructive Lung Disease (BOLD) study to estimate prevalence of dyspnoea in the full sample, as well as in an a priori defined low-risk group (few risk factors or dyspnoea-associated diseases). Dyspnoea was defined by the modified Medical Research Council questions. We used ordered logistic regression analysis to study the association of dyspnoea with site, sex, age, education, smoking habits, low/high body mass index, self-reported disease and spirometry results. Of the 9484 participants, 27% reported any dyspnoea. In the low-risk subsample (n=4329), 16% reported some dyspnoea. In multivariate analyses, all covariates were correlated to dyspnoea, but only 13% of dyspnoea variation was explained. Females reported more dyspnoea than males (odds ratio ∼2.1).
Patients with chronic dyspnoea may learn to fear situations that cue dyspnoea onset. Such dyspnoea-specific cues may then cause anxiety, and worsen or trigger dyspnoea even before commencement of physical activity. We therefore developed an experimental tool to probe emotional processing of dyspnoea for use with neuroimaging in COPD. The tool consists of a computerised task comprising multiple presentations of dyspnoea-related word cues with subsequent rating of dyspnoea and dyspnoea-anxiety with a visual analogue scale. Following 3 development stages, sensitivity to clinical change was tested in 34 COPD patients undergoing pulmonary rehabilitation. We measured internal consistency, sensitivity to clinical change and convergence with established dyspnoea measures (including Dyspnoea-12). Cronbachs alpha was 0.90 for dyspnoea and 0.94 for anxiety ratings. Ratings correlated with Dyspnoea-12 (dyspnoea: r=0.51, P=0.002; anxiety: r=0.54, P=0.001). Reductions in anxiety ratings following pulmonary
BACKGROUND: Dyspnea, or difficult breathing, is common in patients receiving mechanical ventilation; however, dyspnea is not routinely or systematically measured. OBJECTIVE: The primary purpose of this methodological study was to evaluate the test-retest reliability of 5 dyspnea rating scales and the criterion validity of 4 dyspnea rating scales in patients receiving mechanical ventilation. The secondary purpose was to examine the correlations between each of these 5 rating scales and physiological measures of respiratory function. METHODS: The convenience sample consisted of 28 patients on mechanical ventilation during their hospitalization in the intensive care units of a large, inner-city hospital. Patients rated their dyspnea twice at 30-minute intervals on the visual analogue scale, the vertical analogue dyspnea scale, the modified Borg scale, the numerical scale, and the faces scale. Test-retest reliability was computed by using the intraclass correlation coefficient. Criterion validity ...
Restrictive lung disease is a broad term encompassing a number of conditions in which lung volumes are reduced. Dyspnea is a common clinical manifestation of restrictive lung disease and frequently becomes a prominent and disabling symptom that undermines patients ability to function and engage in activities of daily living (especially in those with more advanced restriction). Effective management of this disabling symptom awaits a better understanding of its underlying physiology. In recent decades, our understanding of the mechanisms of dyspnea in restrictive lung disease has been improved by a small, but significant, body of research. One approach to the study of dyspnea is to identify the major qualitative dimensions of the symptom in an attempt to uncover different underlying neurophysiologic mechanisms. This article will review the existing literature on the intensity and qualitative dimensions of dyspnea during exercise in patients with restrictive lung disease. The main focus will be on
TY - JOUR. T1 - Thoracic ultrasound in the differential diagnosis of severe dyspnea. T2 - A reappraisal. AU - Trovato, Guglielmo M.. AU - Rollo, Valeria C.. AU - Martines, G. Fabio. AU - Catalano, Daniela. AU - Trovato, Francesca M.. AU - Sperandeo, Marco. PY - 2013/8/10. Y1 - 2013/8/10. KW - B-line. KW - Dyspnea. KW - Emergency Medicine. KW - Pulmonary edema. KW - Thoracic ultrasound. UR - http://www.scopus.com/inward/record.url?scp=84880917315&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=84880917315&partnerID=8YFLogxK. U2 - 10.1016/j.ijcard.2012.10.057. DO - 10.1016/j.ijcard.2012.10.057. M3 - Article. C2 - 23167999. AN - SCOPUS:84880917315. VL - 167. SP - 1081. EP - 1083. JO - International Journal of Cardiology. JF - International Journal of Cardiology. SN - 0167-5273. IS - 3. ER - ...
TY - JOUR. T1 - Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer. AU - Uronis, Hope. AU - Shelby, Rebecca. AU - Currow, David. AU - Ahmedzai, Sam. AU - Bosworth, Hayden. AU - Coan, April. AU - Abernethy, Amy. PY - 2012/11. Y1 - 2012/11. N2 - Context: Dyspnea is a poorly understood subjective sensation. Existing dyspnea measures fail to adequately address its multidimensionality. A Japanese group developed and validated the Cancer Dyspnea Scale (CDS) for assessing dyspnea in patients with advanced lung cancer. Objectives: We evaluated the validity and reliability of the English version of the CDS (CDS-E) that has 12 items and takes, on average, 140 seconds for individuals to complete. Methods: Eligible patients had advanced lung cancer, consented, and were fluent in English. Participants completed a 100 mm visual analogue scale (VAS), the modified Borg scale, the CDS-E, the Hospital Anxiety and Depression Scale, and ...
Dyspnea is the highly threatening experience of breathlessness experienced by patients with diverse pathologies, including respiratory, cardiovascular, and neuromuscular diseases, cancer and panic disorder. This debilitating symptom is especially prominent in the elderly and the obese, two growing populations in the Western world. It has further been found that women suffer more strongly from dyspnea than men. Despite optimization of disease-specific treatments, dyspnea is often inadequately treated. The immense burden faced by patients, families and the healthcare system makes improving management of chronic dyspnea a priority. Dyspnea is a multidimensional sensation that encompasses an array of unpleasant respiratory sensations that vary according to underlying cause and patient characteristics. Biopsychological factors beyond disease pathology exacerbate the perception of dyspnea, increase symptom severity and reduce quality of life. Psychological state (especially comorbid anxiety and depression),
During the previous phases of the project (Phase I and II), two new field tests have been designed and validated for an integration in a primary care setting in Chronic Obstructive Pulmonary Disease (COPD). These new field tests are 3-min paced-walk test (3MPWT) and 3-min paced step test (3MPST). If the validity and sensitivity of the TM3 could be highlighted, particularly by the reduction of dyspnea level following bronchodilatation, Phase II highlight that the 3MPST does not allow to detect this decrease of dyspnea after bronchodilatation. The use of too high step rates could explain these results through a hypothesis relative to neuromechanical coupling of dyspnea. The main objective of this trial is to follow the investigations on the sensitivity of 3MPST to detect the effects of pharmacological intervention on the exertional dyspnea in COPD patient. The hypothesis of this work is that the use of lower step rates cadences could allow to detect an improvement of exertional dyspnea following ...
A 49\yr\old man presented to our outpatient center complaining of non-productive coughing and exertional dyspnea for just two?weeks. a differential analysis of individuals treated with rituximab, particularly if an individual can be nearing enough time of administration of the fourth cycle of rituximab. pneumonia (PCP) (160 mg/day time??3?times, 120 mg/day time??3?times, 40 mg b.we.d. 5?times, 40 mg q.d.??5?times). His exertional dyspnea got advanced beginning a month after discontinuation from the corticosteroid gradually, and he was described our clinic. He smoked a pack daily for about 30 fifty percent?years, but he previously stop smoking two?years back. There is no palpable superficial lymphadenopathy, no clubbing from the fingertips. Spread velcro\like crackles could possibly be noticed in both basal lungs. Open up in another window Shape 1 Series upper body computed tomography (CT) imaging through the treatment. (a) There is no significant irregular opacities noticeable on upper body CT ...
Background: Chronic Obstructive Pulmonary Disease (COPD) is a rising health problem. Dyspnea causes reduction of functional status and quality of life in it. Pursed Lips Breathing (PLB) and mouth mask use to reduce dyspnea and improve quality of life. Aim of Study: To compare the effect of mouth mask versus pursed lip breathing on ventilatory functions and dyspnea index in patient with chronic obstructive lung disease. Subjects and Methods: Forty men patient presented with chronic obstructive pulmonary disease (FEV1/FVC |0.70) were selected from outpatient clinic at Chest Department Kasr El-Ainy Hospital, age ranged from 50-65 years old. Ventilatory functions, Dyspnea index, oxygen saturation, CATscore ques-tionnaire, were measured pre and post training program. Patients were assigned in two groups. Group (A): Consisted of 20 patients were treated by expiratory breathing through Mouth Mask plus standard chest physiotherapy. Group (B) consisted of 20 patients were treated by pursed lip breathing plus
This essay expounds on fundamental, quantitative elements of the exercise ventilation in children, which was the subject of the Tom Rowland Lecture given at the NASPEM 2018 Conference. Our knowledge about how much ventilation rises during aerobic exercise is reasonably solid; our understanding of its governance is a work in progress, but our grasp of dyspnea and ventilatory limitation in children (if it occurs) remains embryonic. This manuscript summarizes ventilatory mechanics during dynamic exercise, then proceeds to outline our current understanding of mechanisms of dyspnea, particularly during exercise (exertional dyspnea). Most research in this field has been done in adults, and the vast majority of these studies in patients with chronic obstructive pulmonary disease. To what extent conclusions drawn from this literature apply to children and adolescents-both healthy and those with cardiopulmonary disease-will be discussed. The few, recent, pertinent, pediatric studies will be reviewed in ...
Anxiety and depression are highly prevalent comorbidities in chronic obstructive pulmonary disease (COPD) and related to a negative course of disease. We examined the impact of anxiety and depression on functional performance, dyspnea and quality of life in patients with COPD at start and end of an intensive 3-week outpatient pulmonary rehabilitation program (PR).. Before and after PR, 238 patients with COPD (mean age = 62 years) underwent a 6-minute walking test (6MWT). In addition, anxiety, depression, quality of life and dyspnea at rest, after 6MWT and during activities were measured before and after PR.. Except for dyspnea at rest, improvements were found for all outcome measures after PR. Multiple regression analyses showed that before and after PR, anxiety and depression were associated with greater dyspnea after 6MWT and during activities and with reduced quality of life, even after controlling for effects of age, sex, lung function and smoking status. Furthermore, before and after PR ...
Dyspnea is a non-specific symptom that requires fast diagnostics, accurate diagnosis and proper treatment. The most common causes of dyspnea include exacerbation of chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF). Distinction between these two medical conditions seems to be critical in diagnostics of emergencies. At the same time, basic diagnostic tools available in emergency room, such as classic radiography (X-ray) of the chest, electrocardiography (ECG) or b-type natriuretic peptide test, are sometimes ambiguous. Therefore looking for additional diagnostic tool seems to be justified and necessary. Transthoracic lung ultrasound assessment is a simple and easily accessible examination, enabling the early and explicit diagnostics of pulmonary oedema and its distinction from other, non-cardiac causes of dyspnea. This review outlines the current knowledge on the subject of transthoracic lung ultrasound (TLUS), particularly in respect of its clinical usefulness in ...
This chapter examines the findings of various research and studies concerning assessment of dyspnoea. It explains that assessments of the nature and severity of dyspnoea are essential in research studies involving evaluation of the breathless patient and that they provide useful information during the design of new therapeutic and pulmonary rehabilitation strategies. The chapter recommends direct and indirect dyspnoea assessment tools, including the Saint Georges respiratory questionnaire (SGRQ) and the modified Borg or visual analogue scale.
Purpose: The purpose of this study was a) to compare the effect of three different warm-up protocols upon rowing performance and perception of dyspnea, and b) to identify the functional significance of a respiratory warm-up. Methods: A group of well-trained club rowers (N = 14) performed a 6-min all-out rowing simulation (Concept II). We examined differences in mean power output and dyspnea measures (modified CR-Borg scale) under three different conditions: after a submaximal rowing warm-up (SWU), a specific rowing warm-up (RWU), and a specific rowing warm-up with the addition of a respiratory warm-up (RWUplus) protocol. Results: Mean power output during the 6-min all-out rowing effort increased by 1.2% after the RWUplus compared with that obtained after the RWU (P , 0.05) which, in turn, was by 3.2% higher than the performance after the SWU (P , 0.01). Similarly, after the RWUplus, dyspnea was 0.6 ± 0.1 (P , 0.05) units of the Borg scale lower compared with the dyspnea after the RWU and 0.8 ± ...
Suzuki et al claim that their placebo-controlled trial of acupuncture clearly demonstrates that this is a useful adjunctive therapy in reducing dyspnea on exert
Background: Dyspnea is a prevalent condition causing reduced quality of life increasingly by age. The main causes are heart failure (HF), chronic obstructive pulmonary disease (COPD) with less common conditions being ischemic dyspnea, heart disease, atrial fibrillation, asthma, and pulmonary fibrosis. The aim of study was to determine causes of dyspnea in a general population through examination with echocardiography and spirometry and determine age and gender specific prevalence of each condition. Methods: This population based cross-sectional study included 11812 (46.9% were men) participants with answered questionnaire data on dyspnea from the sixth survey of Tromsø study. Independent-sample T-test (for continuous variables) and Chi-square test (for categorical variables) were used to explore significant difference in participant´s characteristics between men and women. Differences between groups were compared with ANOVA for continuous variable and logistic regression (univariate / ...
The management for milder COPD (MRC dyspnea scale score 2):. Usually involves. 1) Smoking cessation with educational programs. 2) Prevention of exacerbations (vaccination). 3) Initiation of bronchodilator therapy. 4) Regular physical activity. 5) Close monitoring of disease status. Management of patients with Grade 3-5 (MRC dyspnea scale):. These individuals are often disabled and require both non-pharmacological and pharmacologic therapies.. NON-PHARMACOLOGICAL THERAPY:. 1) Education:. 2) Smoking cessation:. It is recommended that minimal intervention lasting for at least ≤3 minutes should be offered to every smoker. It is known that intensive counseling with pharmacotherapy results in higher quit rates and should be used whenever possible.. Nicotine replacement therapy in combination with antidepressant (bupropion) doubles the cessation rates.. 3) Reduction of risk factors:. Occupational/environmental/pollutant exposures: Advise to relocate or change occupation. If the latter is not possible ...
After salmeterol, patients could undertake this demanding physical task to a greater peak VO2 than achieved after placebo or during baseline incremental exercise testing. Despite the longer duration and greater peak VE, they reached the same level of peak dyspnoea. Borg ratings of dyspnoea intensity were reduced (by ∼1 unit) at a standardised exercise time compared with placebo. In some patients, the primary exercise-limiting symptom changed from dyspnoea to leg discomfort (or some other new symptom) after bronchodilator therapy.. The present study extends previous work in the area by demonstrating for the first time that, in contrast to dyspnoea/time slopes, dyspnoea/IC relationships during exercise in COPD are not linear (fig. 3⇑) 1, 34. After salmeterol, dyspnoea/IC curves were shifted to the right. Small improvements in the resting IC or FRC of 0.35 L meant that patients could tolerate even greater dynamic hyperinflation during exercise before experiencing intolerable dyspnoea. It is ...
The freeMD virtual doctor has found 325 conditions that can cause Dyspnea. There are 27 common conditions that can cause Dyspnea. There are 44 somewhat common conditions that can cause Dyspnea. There are 67 uncommon conditions that can cause Dyspnea. There are 187 rare conditions that can cause Dyspnea.
Rationale: Dyspnoea is a debilitating and distressing symptom that is reflected in different verbal descriptors. Evidence suggests that dyspnoea, like pain perception, consists of sensory quality and affective components. The objective of this study was to develop an instrument that measures overall dyspnoea severity using descriptors that reflect its different aspects. Methods: 81 dyspnoea descriptors were administered to 123 patients with chronic obstructive pulmonary disease (COPD), 129 with interstitial lung disease and 106 with chronic heart failure. These were reduced to 34 items using hierarchical methods. Rasch analysis informed decisions regarding further item removal and fit to the unidimensional model. Principal component analysis (PCA) explored the underlying structure of the final item set. Validity and reliability of the new instrument were further assessed in a separate group of 53 patients with COPD. Results: After removal of items with hierarchical methods (n=47) and items that ...
Shortness of breath, also called breathlessness or dyspnea is a common symptom of lung or heart disease. Shortness of breath is a very important and useful warning of serious disease, and should not be ignored. On the other hand, when the disease has been diagnosed and is being controlled, persistent shortness of breath can interfere greatly with quality of life. In these cases we try to relieve the symptom.. Doc, I cant breathe! - The experience of not being able to breathe is very unpleasant and can be frightening. The sensation that something is wrong with your breathing is termed shortness of breath or dyspnea. Most of us only feel short of breath when we do things like running up 5 flights of stairs or holding our breath under water. In this case the cure is easy! Slow down, start breathing.. However, dyspnea is a very important symptom of lung and heart disease. This symptom, like pain, is both useful and problematic. Dyspnea is useful because it is often the only warning of ...
TY - JOUR. T1 - Effects of aging on sensation of dyspnea and health-related quality of life in elderly asthmatics. AU - Bellia, Vincenzo. AU - Battaglia, Salvatore. AU - Giardini, Gianluca. AU - Vergani, Carlo. AU - Bellia, Vincenzo. AU - Sandrini, Maria Cristina. PY - 2005. Y1 - 2005. N2 - BACKGROUND AND AIMS: As the awareness of sensory stimuli is often impaired in older subjects, it has been hypothesized that the aging process may influence the perception of dyspnea. This study aimed at evaluating the aging-related difference in perception of spontaneously occurring dyspnea in adult asthmatics and at whether any such aging-related differences have an effect on the health-related quality of life (HRQOL). METHODS: 18 elderly asthmatics (EA) aged ,65 years and 20 young asthmatics (YA) (age range 16-44 years) were recruited. In all subjects, 12-month asthma symptom score and respiratory function were recorded. Dyspnea was measured at rest by the Visual Analog Scale (VAS) and HRQOL by the St. ...
DVAS - Dyspnea Visual Analogue Scale. Looking for abbreviations of DVAS? It is Dyspnea Visual Analogue Scale. Dyspnea Visual Analogue Scale listed as DVAS
Dorothy is 55-years-old, has never smoked, and was well until 1 year ago when she first noticed mild dyspnea on exertion; it has gotten progressively worse.
Many diseases that cause dyspnea can be treated - if possible, such treatment is naturally the best thing to do. However, in many cases the disease cannot be fully cured, and shortness of breath remains a daily problem that limits activities and causes discomfort and suffering. Although research in this area is not as advanced as in pain, there are some options that many people have found helpful. Finding the right course of action for your individual problem may not be easy. The place to start is with a board certified pulmonary physician. Unfortunately, there are only two clinics in the US that specialize in the diagnosis and treatment of difficult dyspnea cases - see this link. There are other physicians competent in dyspnea treatment that may be able to help, but there is no special certification or national register to help you find the right one. Some of the treatment options you and your doctor may wish to explore are listed below - some of these treatments have not been scientifically ...
Experts opinion: - This child has presented with fever, cough and breathlessness. Breathlessness could suggest a cardiac or a pulmonary pathology. Breathlessness in a cardiac problem would either be acute as in pulmonary edema or CCF or may lead to dyspnea on exertion which increases over time. This child has breathlessness going on for 3 months which has almost remained same. Thus cardiac cause seems unlikely. Among, respiratory causes that can cause breathlessness, it could be pneumonia, it could be involvement of bronchi (asthma) or it could be due to pleural pathology (pleural effusion). In this child, inspiration seems to be more of a problem rather than expiration. Hence involvement of bronchi seems unlikely. Also there is no decreased chest movement on one side or localized swelling ruling out pleural effusion. Thus, the problem seems to be in the lung parenchyma. Of the parenchymal lung lesions that can cause cough and breathlessness for 3 months, one should rule out interstitial lung ...
TY - JOUR. T1 - A patient with progressive dyspnoea. AU - Adriaans, B.P.. AU - Samarska, I. V.. AU - de Vries, B.. AU - Bekkers, S. C. A. M.. PY - 2015/7. Y1 - 2015/7. KW - Cardiac amyloidosis. KW - Cardiovascular imaging. KW - Cardiovascular magnetic resonance. KW - Echocardiography. KW - Speckle tracking. KW - Pathology. U2 - 10.1007/s12471-015-0718-1. DO - 10.1007/s12471-015-0718-1. M3 - Article. C2 - 26017890. VL - 23. SP - 399. EP - 401. JO - Netherlands Heart Journal. JF - Netherlands Heart Journal. SN - 1568-5888. IS - 7-8. ER - ...
Opioids are commonly used to relieve dyspnea in palliative medicine, but their effectiveness is unclear. Jennings and colleagues did a systematic review that included a meta-analysis of the effectiveness of opioids in relieving dyspnea. Meta-analysis is necessary because of the small number of studies (only 18 were identified) and the small number of patients in each study (only 1 study had , 20 patients). Overall, opioids showed a beneficial effect in relieving the sensation of breathlessness, but when the type of opioid was examined, only parental and oral opioids reduced breathlessness. Opioid receptors are abundant in the lung, and it has been suggested that nebulized opioids might relieve dyspnea or cough with minimal systemic effects (1). In this review, the nebulized opioids were ineffective compared with placebo in relieving the sensation of breathlessness. However, only 3 studies with 94 patients were combined in this analysis. It should be noted that the other 6 studies of nebulized ...
This paper reports the findings of an exploratory study comparing morphine to placebo for patients with chronic refractory breathlessness.
TY - JOUR. T1 - Associations of depressive symptoms with gender, body mass-index and dyspnea in primary care COPD patients. AU - Chavannes, N.H.. AU - Huibers, M.J.H.. AU - Schermer, T.R.J.. AU - Hendriks, A.. AU - van Weel, C.. AU - Wouters, E.F.M.. AU - van Schayck, C.P.. PY - 2005/1/1. Y1 - 2005/1/1. N2 - Background. It has been suggested that severe COPD is associated with depressive symptoms, possibly linked to exacerbations, dyspnea and hospitalisation. However, scarce data are available in primary care where most patients suffer from mild or moderate disease. Objective. We aimed to reveal associations of depressive symptoms with demographic and clinical characteristics in mild to moderate COPD. Methods. Cross-sectional data on lung function measurements, exacerbation frequency, dyspnea, comorbidity, smoking behaviour, body mass index (BMI), age, gender and depressive symptoms (Beck Depression Inventory) of 147 primary care patients were assessed in multiple logistic regression analyses. ...
Purpose: Dyspnea from hypertensive acute heart failure (AHF) may improve rapidly with BP reduction. Clevidipine (CLV), a short acting arteriospecific calcium antagonist may be effective in this cohort. Our purpose was to compare CLV vs standard of care (SOC) in dyspneic AHF.. Methods: This randomized open label 13 center trial enrolled ED AHF pts with pulmonary congestion, SBP ≥160 mm Hg, and ≥5 on a 10 cm visual analog dyspnea scale (VAS). After setting a 30 min target systolic BP (TBP) range, pts were randomized to CLV or SOC administered per approved labeling.. Results: Of 104 pts treated (safety pop), 54 (51.9%) were female and 83 (79.8%) African American; median (IQR) age, HR, SBP, BNP, initial VAS, and door-to-drug time were 57y (51, 70), 85.5 bpm (70, 96), 180 mmHg (170, 195), 630 pg/mL (353, 1260), 7cm (6, 8.4), and 148.5min (103.5, 219). Therapy was 51 CLV vs 53 SOC (30 nitroglycerin, 16 nicardipine, 4 ISDN and 1 each of hydralazine, nitroprusside, and diltiazem). In the first 30 ...
Description: NWOT Super soft Longer bodice Perfect for layering Size small (2 available) #52,53. Introduction. Aħna kburin li nelenka l-akronimu ta BODE fl-akbar database ta abbrevjazzjonijiet u akronimi. It occurs in 29â 74% of the general cancer patient population, and is most prevalent in advanced disease.1, 2 It is a multifaceted phenomenon with interrelated physiological, psychological, and sociological components that are not well understood. Ta Ta Bodice. $169.00 AUD. Dyspy Drip Mask. Dyspnea is a common symptom of HF, but the burden of dyspnea symptoms varies greatly among patients. Establishing a diagnosis can be challenging because dyspnea … Velvet, embroidered, beaded and metallic boned bodices. Showing page 1. Paris Circa 2004 Top. #### The bottom line Breathlessness-the sensation of discomfort with breathing-is a major cause of impaired activity and suffering worldwide and is common among elderly people in the community and in people with advanced disease.1 w1 Proper ...
The relation between acute dyspnoea and a patients physical and emotional functioning was the most frequent topic of stories told by patients and FCs. Emotional vulnerability stories. Emotional vulnerability was expressed as anxiety experienced in anticipation of and during episodes of increasing or intractable breathlessness that patients could not avoid or manage. In stories where the relation between emotional function and breathlessness was unclear, participants talked of emotional dysfunction as a sign of intractable breathlessness. A complex and circular relation existed between breathlessness and anxiety: participants talked of emotional dysfunction as being the result of both chronic breathlessness and increased physical or emotional activity. Giving concrete expression to the experience of dyspnoea legitimised the illness and the help seeking behaviour of patients and FCs. Vulnerability was also understood in terms of patients perceptions of lessened capacity for interacting with ...
The relation between acute dyspnoea and a patients physical and emotional functioning was the most frequent topic of stories told by patients and FCs. Emotional vulnerability stories. Emotional vulnerability was expressed as anxiety experienced in anticipation of and during episodes of increasing or intractable breathlessness that patients could not avoid or manage. In stories where the relation between emotional function and breathlessness was unclear, participants talked of emotional dysfunction as a sign of intractable breathlessness. A complex and circular relation existed between breathlessness and anxiety: participants talked of emotional dysfunction as being the result of both chronic breathlessness and increased physical or emotional activity. Giving concrete expression to the experience of dyspnoea legitimised the illness and the help seeking behaviour of patients and FCs. Vulnerability was also understood in terms of patients perceptions of lessened capacity for interacting with ...
Idiopathic Pulmonary Fibrosis (IPF) is a life-threatening and devastating disease, for which no cure exists at the moment. Although epidemiological data are scarce, the prevalence of IPF has been reported to range between 20.2/100000 (men) and 13.2/100000 (women) and the incidence between 10.7/100000 (men) and 7.4/100000 (women) in a population based study in New Mexico, USA [1]. Concerning Europe, IPF was found to account for approximately 20-30 % of all ILD cases [2] and a prevalence rate of 16-18/100000 was reported [3]. Hence, there are probably 200000 patients with IPF living in the EU.. IPF is a disease of the middle-aged and affects men slightly more frequently than women. Smoking has been identified as potential risk factor. In approximately 10 - 15% of all cases, a familiar background of IPF can be documented, although the underlying molecular mechanisms and involved genes are largely unknown. Patients with IPF usually complain about exertional dyspnoea, later dyspnoea at rest, ...
Measurement of improvement in dyspnea is based on one OASIS item, M1400, When Is the Patient Dyspneic or Noticeably Short of Breath? A patient identified as 0, no dyspnea at start of care or resumption of care, is excluded from statistical sampling.
mutations 5,6,7,8 . Most patients are asymptomatic and account for 13% to 55% of patients in different series 4,5,6,7,8,9,10,11 .The classic triad of dyspnea, cyanosis, and clubbing is present in only 10% of patients with PAVMs 4 . The direct communication between the pulmonary and systemic circulation bypasses the capillary bed and this right-to-left-shunt causes hypoxemia and the absence of a filtering capillary bed allows embolism that can reach the systemic arteries inducing clinical sequelae, especially in the cerebral circulation with brain abscesses and stroke. These processes account for clinical features such as dyspnea, fatigue, hemoptysis, cyanosis and polycythemia 12 . The most common presenting symptom is dyspnea on exertion (31% to 67% of patients), and severity of dyspnea is related to the degree of hypoxemia and magnitude of the right-to-left shunt. Majority of the patients with PAVMs tolerate hypoxemia well and are relatively asymptomatic unless the arterial oxygen pressure is ...
Each person may experience dyspnea in a slightly different way. You may be asked to describe your breathlessness as mild, moderate, or severe. Dyspnea may keep you from doing things you normally do with ease. Your healthcare provider may ask you how your dyspnea affects your daily life and quality of life. Tell your provider how it impacts how far you can walk, how you eat, or even how you talk. To help you talk with your healthcare provider about dyspnea, it may help to keep track of how it affects you. Keep a journal of when you have it, what makes it better, and what makes it worse. Your provider may also order tests to find out what is causing your dyspnea, if the cause isnt clear. These might include blood tests or tests of your heart or lungs. ...
We investigated 5 biomarkers (hs-cTnT, hs-CRP, Gal-3, Cys-C, and NT-proBNP) with a distinct pathophysiological background for short-term risk stratification in 603 patients with dyspnea presenting to the ED. hs-cTnT, hs-CRP, Cys-C, and NT-proBNP were independent predictors of 90-day all-cause mortality and risk increased substantially as more biomarkers were elevated above the cut point. Moreover, we present a simple and straightforward score for short-term risk stratification based on biomarkers in combination with clinical risk factors. This MARKED-risk score is able to identify patients with very low, intermediate, and excessive high risk for both short- and long-term mortality.. Because the evaluation of dyspneic patients in the ED is difficult and an accurate diagnosis cannot always be acquired promptly, a non-diagnosis-specific risk score is helpful in clinical practice. Especially for decision making in an acute setting, short-term risk assessment is important. Several biomarkers have ...
Discussion. In this randomized crossover trial, conducted in patients with severe COPD, we found that the application of 1cmH2O PEP during the execution of 6MWT can improve the distance walked to the same extent as the application of 10cmH2O PEP, without affecting the cardiovascular response to exercise. We did not find any effect of PEP on dyspnea at the end of exercise and post-exertion lung dynamic volumes, particularly IC, SVC, FVC and ERV. Moreover, we found that the improvement of 6MWD is greater in patients with no or low dynamic hyperinflation when a low PEP is applied.. So far, only two other crossover randomized trials have investigated the effects of a PEP device on 6MWD, with contrasting results.. In 2013, Nicolini et al.11 found that a threshold PEP of 5cmH2O improved the distance walked during the 6MWT in patients with moderate-to-severe COPD. They also demonstrated a significant improvement in post-exercise oxygen saturation and a decrease in peak heart rate during the 6MWT with ...
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation Ellen Tufvesson, Leif Bjermer, Marie Ekberg Respiratory Medicine and Allergology, Department of Clinical Sciences, Lund University, Lund, Sweden Background: Some patients with chronic obstructive pulmonary disease (COPD) show increased airway inflammation and bacterial colonization during stable phase. The aim of this study was to follow COPD patients and investigate chronic colonization with pathogenic bacteria during stable disease phase, and relate these findings to clinical parameters, inflammatory pattern, lung function, and exacerbations. Methods: Forty-three patients with COPD were included while in a stable state and followed up monthly until exacerbation or for a maximum of 6 months. The patients completed the Clinical COPD Questionnaire and Medical Research Council dyspnea scale questionnaires, and exhaled breath condensate
Dyspnea is a condition that causes difficult or labored breathing, often caused by heart conditions. Two types of dyspnea are significant in cardiac illness. Dyspnea on exertion is the shortness of breath that occurs with increasing activity. Paroxysmal nocturnal dyspnea is a shortness of breath that awakens a person from sleep. Both are significant symptoms in cardiac disease.. ...
Dyspnea is a condition that causes difficult or labored breathing, often caused by heart conditions. Two types of dyspnea are significant in cardiac illness. Dyspnea on exertion is the shortness of breath that occurs with increasing activity. Paroxysmal nocturnal dyspnea is a shortness of breath that awakens a person from sleep. Both are significant symptoms in cardiac disease.. ...
The effects of positioning and pursed-lip breathing exercise on dyspnea and anxiety status in patients with chronic obstructive pulmonary disease
Bronchial challenge tests are used to evaluate bronchial responsiveness in diagnosis and follow-up of asthmatic patients. Challenge induced cough has increasingly been recognized as a valuable diagnostic tool. Various stimuli and protocols have been employed. The aim of this study was to compare cough and dyspnea intensity induced by different stimuli. Twenty asthmatic patients underwent challenge tests with methacholine, bradykinin and exercise. Cough was counted during challenge tests. Dyspnea was assessed by modified Borg scale and visual analogue scale. Statistical comparisons were performed by linear mixed-effects model. For cough evaluation, bradykinin was the most potent trigger (p | 0.01). In terms of dyspnea measured by Borg scale, there were no differences among stimuli (p | 0.05). By visual analogue scale, bradykinin induced more dyspnea than other stimuli (p ≤ 0.04). Bradykinin seems to be the most suitable stimulus for bronchial challenge tests intended for measuring cough in association
Background: While the efficacy of pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD) has been well established, emerging evidence also suggests its benefit in idiopathic pulmonary fibrosis (IPF). However, the differences and similarities between how PR affects diseases with different physiologies remain unknown. Objective: This study aimed to compare the efficacy of PR in COPD and IPF patients by performing multifactorial evaluation with various exercise capacity measurements, and dyspnea and health-related quality of life (QoL) assessment. Methods: Twenty-two IPF patients (%vital capacity: 72%) and 27 COPD patients (%forced expiratory volume1: 43%) were recruited. Subjects who completed a 10-week outpatient PR program were analyzed. We assessed five exercise capacity indicators (6-minute walking distance, incremental shuttle walking distance, endurance time, peak work rate, and peak values for oxygen uptake [peak VO2]), dyspnea (Baseline Dyspnea Index: BDI), and ...
Looking for online definition of expiratory dyspnea in the Medical Dictionary? expiratory dyspnea explanation free. What is expiratory dyspnea? Meaning of expiratory dyspnea medical term. What does expiratory dyspnea mean?
Looking for online definition of Traube dyspnea in the Medical Dictionary? Traube dyspnea explanation free. What is Traube dyspnea? Meaning of Traube dyspnea medical term. What does Traube dyspnea mean?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
Background Dyspnea is a distressing and functionally limiting symptom that patients with heart failure commonly experience. A valid instrument to quantify dyspnea for comparison of groups and for illness management is important.. Objective To validate the Chinese version of the Modified Pulmonary Functional Status and Dyspnea Questionnaire.. Methods The Chinese version was developed by using translation and back translation and was tested in Taiwan in 88 patients who had heart failure but no pulmonary disease or comorbid conditions limiting physical function. Data on a Taiwanese subsample (n=30) were compared with data on 30 patients in the United States matched by sex, age, and severity of disease to determine the equivalence of the Chinese and English versions. Construct validity was assessed by testing the hypothesis that health-related quality of life measured by using the Minnesota Living With Heart Failure Questionnaire is associated with the score on the dyspnea questionnaire. Reliability ...
Definition of exertional dyspnea. Provided by Stedmans medical dictionary and Drugs.com. Includes medical terms and definitions.
Reduced exercise tolerance and exercise-induced dyspnoea are common complaints affecting many older persons, with prevalence rates varying between 20% and 60%. Both symptoms often coexist and are associated with an increased risk of adverse health outcomes and reduced quality of life. In approximately two third of patients these complaints have ... read more a pulmonary or cardiac cause, with heart failure and chronic obstructive pulmonary disease (COPD) as most common underlying disorders. For both diseases effective interventions are available. We performed a diagnostic cluster randomized trial in frail elderly with dyspnoea or reduced exercise tolerance to quantify the yield of such a screening strategy compared to usual care. Primary care practices were randomized to the diagnostic-treatment strategy (screening) or care as usual. Frail community-dwelling persons aged 65 years and older were selected from the electronic medical files of the participating general practitioner. Frailty was ...
Our understanding of the mechanisms of dyspnoea in fibrotic interstitial lung disease (ILD) is incomplete. The aims of this study were two-fold: 1) to determine whether dyspnoea intensity is better predicted by neural respiratory drive (NRD) or neuromechanical uncoupling (NMU) of the respiratory system in fibrotic ILD, and 2) to examine the effect of breathing 60% oxygen on NRD, NMU and dyspnoea ratings.Fourteen patients with fibrotic ILD were included. Visit 1 comprised a familiarisation incremental cycle exercise test, Visit 2 comprised a normoxic incremental cycling test to address Aim 1, and Visits 3 and 4 consisted of constant-load cycling while breathing room air or 60% oxygen to address Aim 2 ...
Background-The Chronic Respiratory Questionnaire (CRQ) is an established measure of health status for chronic obstructive pulmonary disease (COPD). It has been found to be reproducible and sensitive to change, but as an interviewer led questionnaire is very time consuming to administer. A study was undertaken to develop a self-reported version of the CRQ (CRQ-SR) and to compare the results of this questionnaire with the conventional interviewer led CRQ (CRQ-IL). Methods-Fifty two patients with moder- ate to severe COPD participated in the study. Subjects completed the CRQ-SR 1 week after completing the CRQ-IL, and a further CRQ-SR was administered 1 week later. For patients in group A (n=27) the dyspnoea provoking activities that they had previously selected were transcribed onto the second CRQ-SR, while patients in group B (n=25) were not informed of their previous dyspnoea provoking activities when they completed the second CRQ-SR. To assess the short term reproducibility and reliability of ...
A 47 year-old female presents to the ED via basic life support ambulance with sudden onset of severe dyspnea after a witnessed choking episode while taking her daily medications. On arrival: Morbidly obese female sitting upright in the stretcher with a non-rebreather mask. She appears diaphoretic with severe dyspnea …. Read More » ...
A 47 year-old female presents to the ED via basic life support ambulance with sudden onset of severe dyspnea after a witnessed choking episode while taking her daily medications. On arrival: Morbidly obese female sitting upright in the stretcher with a non-rebreather mask. She appears diaphoretic with severe dyspnea …. Read More » ...
Logeart D, Saudubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol. 2002;40:1794-800. 12446063 (All 2003 articles were reviewed for relevancy, and abstracts were last revised in 2009 ...
Numerous case reports, uncontrolled studies, and small randomized placebo-controlled trials have investigated the role of aerosolized opioids in the treatment of both dyspnea and pain. Recently, aerosolized furosemide was studied for the treatment of dyspnea. A direct effect on either pulmonary stretch receptors or irritant receptors has been proposed to explain the apparent effectiveness of these drugs. A review of the literature found 37 studies and reports: 23 on aerosolized opioids to treat dyspnea, 7 for analgesia, and 7 on aerosolized furosemide. In general, prospective double-blind randomized placebo-controlled trials have investigated the effects of aerosolized opioids on dyspnea and exercise tolerance in patients with stable chronic cardiopulmonary disease, and found no effect. In contrast, the vast majority of studies found that aerosolized opioids relieved dyspnea better than parenteral opioids and with less systemic adverse effects in patients with terminal lung cancer and cystic ...
SUMMARY. A group of 10 patients who complained of exertional dyspnea largely after exercise and who had normal physical examination and chest roentgenograms is described. Chronic obstructive lung disease, pulmonary vascular disease, and interstitial pneumonitis were excluded because mechanics of breathing and respiratory gas exchange were normal. Comparison with normal volunteers and with patients with diffuse lung disease showed that their symptoms were the result of inappropriate postexercise hyperventilation. Three minutes after completion of the exercise their PCO2 averaged 23 mm Hg compared with 37 mm Hg for normals and 31 mm Hg for patients with diffuse lung disease. The decreased PCO2 in the airways produced bronchospasm that could be reversed by adding carbon dioxide to the inspired gas. Dyspnea appeared to result from increased work of breathing, in part from hyperventilation and in part from increased resistance to air flow. In some, the postexercise hyperventilation could be related ...
Introduction The association of chest pain versus dyspnea with demographics, coronary angiographic findings, and outcomes of patients undergoing coronary angiography is unfamiliar. (hazard percentage (HR) = 1.07, < 0.0001), serum creatinine (HR = 1.5, < 0.0001), body mass index (HR = 0.93, = 0.005), and obstructive CAD graft (HR = 3.2, = 0.011). Conclusions Individuals undergoing coronary angiography showing with dyspnea were older and experienced higher serum creatinine, lower LVEF, more frequent cardiogenic shock, less obstructive CAD, and less percutaneous coronary treatment compared to individuals presenting with chest pain but related 2-yr mortality. = 0.02) and typical angina pectoris (OR = 1.9, = 0.01) were associated with obstructive CAD [3]. Inside a meta-analysis of 6 studies of 5,753 sufferers with dyspnea and 24,491 DAMPA sufferers with chest discomfort as the scientific indication for tension testing, there is no DAMPA difference in the incidence of ischemia between your combined ...
A. Cough and dyspnea due to heat-phlegm, cough due to dry-phelgm. This herb is sweet, cold and moist in property. It is good at clearing lung heat, moistening dryness of lung to resolve heat-phlegm and dry-phlegm. For productive cough and dyspnea due to lung heat, it is singly used in Run Fei San from Xuan Ming Lun Fang to clear lung and resolve phlegm. For exuberant phlegm manifested by cough, dyspnea, yellow phlegm difficult in expectoration and stuffiness and fullness of chest, it is combined with heat-phlegm-clearing and resolving herbs. For instance it is combined with Dan Nan Xing, Huang Qin and Zhi Shi, etc. in Qing Qi Hua Tan Wan from Yi Fang Kao (Verification of Medical Prescription). For dry-heat damaging lung manifested by non-productive cough or scanty and sticky phlegm with difficulty in expectoration, it is also combined with lung-clearing and dryness-moistening herbs, and phlegm-resolving antitussives. For instance it is combined with Tian Hua Fen and Chuan Bei Mu recorded in Yi ...
Acute dyspnea is a common chief complaint among patients who visit an emergency room and presents diagnostic challenges for clinicians in both identifying the etiology and determining the clinical severity. The study of biomarkers in the prognostication and risk stratification of these patients has been increasing, including the investigation of the prognostic value for mid-regional pro-adrenomedullin (MR-proADM). Areas Covered: In this review, the authors cover what is known about MR-proADM testing in patients presenting with acute dyspnea and the supporting evidence of its prognostic value in common conditions in medical patients with acute dyspnea, including acute heart failure, community acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease, and acute pulmonary embolism ...
Between January 1998 and January 2000, we recruited patients seen at the emergency department of or admitted to the Montreal Heart Institute with a primary diagnosis of congestive heart failure. The diagnosis required the presence of both signs (at least 1 of tachycardia, gallop rhythm, increased jugular venous pressure [, 10 cm] or pulmonary crackles) and symptoms (at least 1 of dyspnea at rest or minimal effort, paroxysmal nocturnal dyspnea or orthopnea). Patients also had either radiologic confirmation of their congestive heart failure or a known impaired left ventricular ejection fraction (, 45%). Echocardiography was conducted to document left ventricle function if it had not been performed within the previous 6 months. At discharge, all consecutive eligible patients were approached to participate in the study. In order to maximize the generalizability of the results, exclusion criteria were kept to a minimum: a primary diagnosis of acute myocardial infarction, discharge to a chronic care ...
Patients with COPD are often under treated, leading to much preventable morbidity, lost productivity, and economic cost. Identifying at risk patients could substantially improve outcomes.. The FEV1 is the single best variable to stratify COPD severity. However, it does not accurately predict dyspnoea symptoms, exercise tolerance, and mortality. This is because COPD is a systemic disease, and airflow limitation alone does not capture all aspects of disease severity. FEV1 may overestimate exercise tolerance because of dynamic hyperinflation or other non-ventilatory limitations. On the other hand, dyspnoea may even be absent because the patient has unconsciously narrowed their envelope of activity. Cigarette smoking also contributes to other causes of mortality in COPD, including cancer and cardiovascular disease, and is not reflected in the FEV1.. The study by Celli et al introduces the BODE index, which promises to be a very useful prognostic tool. The BODE index was constructed by broadening ...
To the Editors:. I read with interest the recent review article by Galiè et al. [1] on the use of combination therapy in pulmonary arterial hypertension (PAH). The authors raised a number of important points, including the use of a goal-oriented approach to combination therapy and the need for regular monitoring in order to achieve optimal results for an individual patient.. In support of this approach, I would like to present the case of a 40-yr-old female, who had complained of progressive dyspnoea on exertion during a third pregnancy, becoming particularly noticeable after delivery in March 2005. Her two previous pregnancies had been uneventful and she had no relevant previous medical history. She was initially diagnosed as suffering from fatigue and post-partum depression in August 2005.. The patient was eventually referred to a cardiologist in October 2005, where she was classified as being in New York Heart Association/World Health Organization Functional Class (NYHA/WHO FC) III, with a ...
Is Dyspnoea a common side effect of Oxycontin? View Dyspnoea Oxycontin side effect risks. Male, 17 years of age, took Oxycontin 260 Mg In Total. Patient was hospitalized.
Feeling DYSPNOEA while using Clonidine? DYSPNOEA Causes, Patient Concerns and Latest Treatments and Clonidine Reports and Side Effects.
Current recommendations for the treatment of asthma include using inhaled bronchodilators as maintenance therapy and systemic corticosteroids for severe exacerbations. Corticosteroids take time (from six to 12 hours) to become effective and should not be used alone. However, some physicians believe that intravenous (IV) steroids provide relief in a short period of time. Noseda and associates studied the early effect of IV methylprednisolone on dyspnea in patients with acute exacerbations of asthma.. The study design was a randomized, placebo-controlled, double-blind crossover trial of 25 patients with asthma. Patients enrolled in the study had an established diagnosis of asthma and presented to the study center with increasing dyspnea. In addition, the patients had to rate their dyspnea as being at least very slightly short of breath. Patients were randomly assigned to receive 125 mg of IV methylprednisolone or placebo in a saline solution/steroid sequence or the reverse. They were assessed ...
Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey Caitlyn T Solem,1 Shawn X Sun,2 Sizhu Liu,1 Cynthia Macahilig,3 Monica Katyal,3 Xin Gao,1 Andrew Shorr4 1Pharmerit International, Bethesda, MD, 2Forest Research Institute, Jersey City, NJ, 3Medical Data Analytics, Parsippany, NJ, 4Pulmonary Critical Care, Washington Hospital Center and Georgetown University, Washington, DC, USA Objective: This study aimed to compare spirometry- and risk + symptom-based classification systems to physician-based severity assessment and find which system is most predictive of patient-reported health status, as measured by the St Georges Respiratory Questionnaire for COPD (chronic obstructive pulmonary disease; SGRQ-C).Materials and methods: In this chart review/patient survey, 99 physicians recruited patients with physician-assessed severe or very severe COPD who had recently experienced a moderate or severe
Pulmonary rehabilitation (PR) has been defined as a multi-disciplinary program of care for patients with chronic respiratory impairment that is individually tailored and designed to optimize physical and social performance and autonomy.(1). As lung reserve declines, dyspnea worsens and independent daily activity performance erodes. PR provides multidisciplinary training to improve the patients ability to manage and cope with progressive dyspnea.(2). Although PR efforts are often focused on patients with chronic obstructive pulmonary disease (chronic bronchitis and/or emphysema),(3-6) other conditions appropriate for this process include, but are not limited to, patients with asthma,(7) interstitial disease,(8) bronchiectasis,(8) cystic fibrosis,(9-11) chest wall diseases,(8) neuromuscular disorders,(12,13) ventilator dependency,(14,15) and before and after lung surgery for transplantation,(16) volume reduction,(17,18) or cancer.(19,20). PR services include critical components of assessment, ...
In this randomised, crossover trial, 22 patients with severe chronic obstructive pulmonary disease climbed six flights of stairs (108 steps) twice, under two test conditions: (1) energy conservation technique (ECT): participants were asked to rest for at least 5 seconds every three steps and (2) control condition: participants climbed the stairs at their own pace. Significant lower dyspnoea (primary outcome), leg discomfort, minute ventilation and capillary blood lactate under the ECT condition were found, with no change in total task time. CLINICAL TRIAL REGISTRATION: NCT03564028 ...
Bronchial asthma is a heterogeneous respiratory condition which can be mimicked by a wide range of pathologies including upper airways stenosis. The accurate diagnosis of asthma, as with other conditions, may be influenced by fixation errors, which are common in medicine and occur when a physician concentrates on only one element of a clinical case without considering other relevant aspects. Here we report a challenging case characterized by the contemporaneous presence of a common disease, asthma, together with a rare respiratory disease, idiopathic tracheal stenosis. The 56-year-old female patient, a former smoker, was referred to our outpatient clinic for exertional dyspnea and persistent wheezing. There were no other respiratory or systemic symptoms over the past three months, and a psychological component was suspected. Spirometry with flow-volume evaluation and bronchoscopy were the key elements to establish the diagnoses and provide treatments. Once the diagnosis of asthma was confirmed, the
Breathlessness is a major cause of suffering and distress, and little is known about the trajectory of breathlessness near death.To determine the trajectory and clinical-demographic factors associated with breathlessness in the last week of life in patients receiving specialist palliative care.This was a prospective, longitudinal cohort study using national data on specialist palliative care from the Australian Palliative Care Outcomes Collaboration. We included patients in the Australian Palliative Care Outcomes Collaboration who died between July 1, 2013 and June 30, 2014 with at least one measurement of breathlessness on a 0-10 numerical rating scale in the week before death. The trajectory and factors associated with breathlessness were analyzed using multivariate random-effects linear regression.A total 12,778 patients from 87 services (33,404 data points) were analyzed. The average observed breathlessness was 2.1 points and remained constant over time. Thirty-five percent reported moderate ...
A 66-year-old woman presented with progressive exertional dyspnoea, productive cough and dysphonia, particularly when singing; she also experienced a dry obstructed nose, sore mouth and mild dysphagia. She had previously been diagnosed with autoimmune disease affecting her eyes, nasal passages, oropharynx and oesophagus, for which she had received treatment with prednisolone and cyclophosphamide. Immunosuppression continued with azathioprine. She also suffered from aortic stenosis and hypothyroidism, which was treated with levothyroxine. No perinatal respiratory difficulties were known and she had never been intubated. Despite being a non-smoker, she had had frequent lower respiratory tract infections.. Physical examination showed no additional signs but chest radiography revealed ill-defined consolidation in the right upper lobe. Bronchoscopy was performed to exclude mycobacterial infection and showed an abnormal supraglottic region with a ring-like narrowing with scarring extending posteriorly ...
We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennecs cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the ...
The ERS-education website provides centralised access to all educational material produced by the European Respiratory Society. It is the worlds largest CME collection for lung diseases and treatment offering high quality e-learning and teaching resources for respiratory specialists. This distance learning portal contains up-to-date study material for the state-of-the-art in Pulmonology.
Symptoms of allergies This can leave a person feeling short of breath. Shortness of breath wakes me occasionally at night and is bothersome during the day, causing frequent yawning. Symptoms include wheezing, coughing, severe shortness of breath, chest tightness, chest pain, and inability to speak due to breathlessness. In this category, we can also include respiratory failure due to coronavirus. Hello I have shortness of breath problems last two weeks .doctor give me sinucus spray .its give me some relief but again same I feel my chest not free with take breath not take deep breath .and many yawns some complete some not .when yawn and breath complete i free free otherwise irritate me.please help and let me know what i can do . Dyspnea or shortness of breath is one of the symptoms of SARS-CoV-2 coronavirus infection, the cause of the current COVID-19 pandemic. Shortness of breath; Dizziness; Sweating; Severity of this condition can vary. 0 comment. You may experience occasional chest tightness ...
Clinical signs and symptoms for pulmonary embolism are nonspecific; therefore, patients suspected of having pulmonary embolism-because of unexplained dyspnea, tachypnea, or chest pain or the pre... more
How do you distinguish right sided heart failure from left sided heart failure? Question: What is the most common cause of right sided hear failure? (Scroll down for answer) Left sided heart failure is more common and it associated with these 3 main symptoms: 1) Dyspnea on exertion 2) Cardiac Dilation 3) Pulmonary edema *…
Shiber JR, Santana J (May 2006). "Dyspnea". The Medical Clinics of North America. 90 (3): 453-79. doi:10.1016/j.mcna.2005.11. ...
... dyspnea) •Fast heart rate (tachycardia) •Poor feeding Preexisting diabetes mellitus of a pregnant mother is a risk factor that ...
Definition of Dyspnea MedicineNet. Last Editorial Review: 11/1/1998] Levene, Malcolm I.; David Ian Tudehope; Michael John ... Still, many simply define dyspnea as difficulty in breathing without further specification, which may confuse it with e.g. ... The other way around, labored breathing or tachypnea can voluntarily be performed even when there is no dyspnea. Presentations ... Labored breathing is distinguished from shortness of breath or dyspnea, which is the sensation of respiratory distress rather ...
... dyspnoea; chest pain; palpitations and mild pyrexia. Rare: Uterine rupture, severe hypotension, coronary spasms with subsequent ...
... dyspnoea; cough; sputum; shortness of breath; headaches; malaise; and generalised aches. Cyanosis Mild fever Pulmonary ...
See pronunciation information at dyspnea. Paroxysmal nocturnal dyspnoea Trepopnea Dorland's Illustrated Medical Dictionary (32 ... Platypnea or platypnoea is shortness of breath (dyspnea) that is relieved when lying down, and worsens when sitting or standing ...
The Diagnosis of Stupor and Coma by Plum and Posner, ISBN 0-19-513898-8 Davis, Mellar (June 30, 2018). "Opioids, Dyspnea and ...
Mukerji, bVaskar (1990). "Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea". In Walker, H. Kenneth; Hall, W. Dallas; Hurst ... See pronunciation information at dyspnea. Paroxysmal nocturnal dyspnoea Trepopnea "Orthopnoea , Definition of Orthopnoea by ... Orthopnea or orthopnoea is shortness of breath (dyspnea) that occurs when lying flat, causing the person to have to sleep ... This is different from the dyspnea experienced by someone with lung parenchymal pathology (both restrictive and obstructive) ...
See pronunciation information at dyspnea. List of terms of lung size and activity Respiratory rate Tachypnea Bradypnea Apnea ...
See pronunciation information at dyspnea. Medicine portal List of terms of lung size and activity Bradypnea http://www.aasmnet. ...
See pronunciation information at dyspnea. Control of respiration Hypoventilation List of terms of lung size and activity Whited ...
"Exercise induced dyspnea in the young. Larynx as the bottleneck of the airways". Respiratory Medicine. 103 (12): 1911-1918. doi ...
Affected persons usually present with dyspnea. On radiological studies, thickening of the pleura can be visualized extending ... Affected persons are usually young adults that present with progressive dyspnea. On radiological studies, diffuse lesions are ...
Togawa, Kiyoshi; Konno, Akiyoshi; Miyazaki, Soichiro; Yamakawa, Koji; Okawa, Masako (1988). "Obstructive Sleep Dyspnea: ...
Emilia suffered from recurrent coughs and dyspnea; at 11 she began having hemorrhages from the upper gastrointestinal tract, ...
Fever poor appetite anterior fontanelle bulging seizures jitteriness dyspnea irritability anorexia vomiting diarrhea abdominal ... and dyspnea. The only method to determine if meningitis is the cause of these symptoms is lumbar puncture (an examination of ...
Gardner, SC; Majercik, SD; VanBoerum, D; Macfarlane, JR (2013). "Man, 57, with dyspnea after chiropractic manipulation". ...
This results in rhinorrhea, itchiness, dyspnea, and anaphylaxis. Depending on the individual, the allergen, and the mode of ...
A 60-Year-Old Woman with Increasing Dyspnea". The New England Journal of Medicine. 374 (23): 2269-79. doi:10.1056/ ...
Nausea, vomiting, reduced appetite, urinary retention, dyspnea, weakness. Potentially fatal reactions are due to ...
"Rostan's asthma": Known today as paroxysmal nocturnal dyspnea. A type of cardiac asthma associated with heart disease, such as ...
Symptoms included angina and dyspnoea. In 35-40% of unexplained youth deaths, genetic alterations in genes involved in the ...
Dyspnea and chest pain commonly occurs during daily activities. Sometimes, syncope (fainting) may happen. On physical ...
Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. ...
It is marked by cough, dyspnea, anorexia and constipation. Lungworms which cause parasitic bronchitis include nematodes of the ...
Some symptoms include fever, cough, and dyspnea (difficulty breathing). Radiologic examination may reveal an alveolar ...
This edema is accompanied by dyspnea and occasionally asphyxia. "Halzoun - definition of halzoun by Medical dictionary". ...
Typical symptoms include dyspnea, cough, chest pain and fatigue. At least some cases appear to be due to mutations in the ...
Common symptoms include cough, dyspnea, weight loss, and debility. Over 70% of patients with small-cell carcinoma present with ... with radiotherapy added only to palliate symptoms such as dyspnea, pain from liver or bone metastases, or for treatment of ...
Respiratory signs include coughing, serous nasal discharge, dyspnea and tachypnea. Signs may worsen if a secondary infection ...
Despite the feeling of suffocation, dyspnea does not cause suffocation or death, and patients may experience dyspnea even with ... Dyspnea in pregnancy. Author(s): Shih-Yi Lee, Ding-Kuo Chien, Chien-Hsuan Huang, Shou-Chuan Shih, Wei-Cheng Lee, Wen-Han Chang ... Dyspnea may be caused by physical factors, such as an airway obstruction, or biological factors, such as a decreased amount of ... Dyspnea is a symptom that may be accompanied by other symptoms, such as chest tightness, anxiety, and a feeling of suffocation ...
Cough, pain and dyspnoea: similarities and differences. Gracely RH, Undem BJ, Banzett RB. Pulm Pharmacol Ther. 2007;20(4):433-7 ... Measurement of dyspnea: word labeled visual analog scale vs. verbal ordinal scale. Lansing RW, Moosavi SH, Banzett RB. Respir ... Focus on "Dyspnea as a noxious sensation: inspiratory threshold loading may trigger diffuse noxious inhibitory controls in ... Dyspnea: mechanisms, evaluation and treatment. Burki, Tobin, Guz, Sharp, Banzett and Mahler, 1988. No abstract available.. ...
General Hospital Dyspnea Clinic is staffed by world-class specialists who evaluate and treat patients with unexplained dyspnea ... Dyspnea Clinic. The Massachusetts General Hospital Dyspnea Clinic is staffed by world-class specialists who evaluate and treat ... Experts in the Diagnosis and Care of Dyspnea Patients. The Mass General Dyspnea Program is led by Gregory Lewis, MD, who is ... Advanced Diagnostics & Care for Dyspnea Patients. Unexplained dyspnea, also known as shortness of breath, affects people of all ...
Shortness of breath Dyspnea, or breathing discomfort, is a frequently reported symptom, often the manifestation of ... Sabol V. (2019) Dyspnea. In: Gellman M. (eds) Encyclopedia of Behavioral Medicine. Springer, New York, NY. * .RIS Papers ... Dyspnea, or breathing discomfort, is a frequently reported symptom, often the manifestation of cardiopulmonary and ... According to the American Thoracic Society, dyspnea is a term used to "characterize a subjective experience of breathing ...
Charlottesville, VA) Rescue Squad (EMT) Guidelines for dealing with dyspnea:. RESPIRATORY DISTRESS / DYSPNEA. Check ABCs. If ...
Dyspnea comes in varying degrees and kinds. Dyspnea on Exertion Everyone feels out of breath when they exercise hard enough, ... For Patients‎ , ‎Basic Dyspnea Information‎ , ‎ Do I have shortness of breath? Shortness of breath (dyspnea) is a symptom, ... Dyspnea at Rest It is never normal to feel short of breath when you are not exercising, and it can be very troubling. If you ... Contact Us Dyspnea Center at Beth Israel Deaconess Medical Center, Harvard Medical School. ...
Paroxysmal nocturnal dyspnea or paroxysmal nocturnal dyspnoea (PND) is an attack of severe shortness of breath and coughing ... CS1 maint: discouraged parameter (link) Mukerji, bVaskar (1990). "Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea". In ... Treatment for paroxysmal nocturnal dyspnea depends on the underlying cause. Options often include oxygen, diuretics, heart ...
A new study only underscores our lack of knowledge on the pathogenesis and clinical importance of exertional dyspnea in CHF. ... Does dyspnea really impair activity in chronic heart failure? ... Our thinking about dyspnoea in heart failure has long been ... So do patients with chronic heart failure stop exercising with dyspnoea or because of dyspnoea? If we were able to suppress the ... Understanding dyspnoea became more difficult when we tried to decipher the genesis of the symptom in patients with chronic ...
Definition of exertional dyspnea. Provided by Stedmans medical dictionary and Drugs.com. Includes medical terms and ...
I have been to multiple doctors and we are still not sure what is causing the dyspnea. I have seen a pulmonologist, a ... Unknown Dyspnea Justen I have been to multiple doctors and we are still not sure what is causing the dyspnea. I have seen a ... cardiologist although for the tachycardia the cardiologist tried to place my on a beta blocker which is not helping the dyspnea ...
The total dyspnoea model comprehensively defines the suffering of the individual experiencing dyspnoea, describing the ... Total dyspnoea.. Abernethy AP1, Wheeler JL.. Author information. 1. Department of Medicine, Division of Medical Oncology, Duke ... In the past year, studies in the field of dyspnoea have explored a host of new approaches spanning pharmacological, mechanical ... This paper introduces total dyspnoea as a new paradigm that provides palliative care clinicians with an organizing structure ...
dyspnea Dyspnea is a condition that causes difficult or labored breathing, often caused by heart conditions. Two types of ... Dyspnea on exertion is the shortness of breath that occurs with increasing activity. Paroxysmal nocturnal dyspnea is a ...
Episodic dyspnea answers are found in the Diagnosaurus powered by Unbound Medicine. Available for iPhone, iPad, Android, and ... 5minute, www.unboundmedicine.com/5minute/view/Diagnosaurus/114603/all/Episodic_dyspnea. Zeiger RF. Episodic dyspnea. ... Episodic dyspnea is a topic covered in the Diagnosaurus. To view the entire topic, please sign in or purchase a subscription. ... Zeiger, R. F. (2014). Episodic dyspnea. In Diagnosaurus (4th edition). McGraw-Hill Education. Retrieved May 26, 2020, from ...
McGill University Dyspnea 2018 Scientific Program Committee Members Dennis Jensen, McGill University Sara Abdallah, McGill ... Dyspnea 2018 Meeting Co-Chairs Dennis Jensen, McGill University Sara Abdallah, ... Dyspnea 2018 Meeting Co-Chairs. Dennis Jensen, McGill University. Sara Abdallah, McGill University. Dyspnea 2018 Scientific ... For information on Dyspnea 2018 in Montreal, please contact:. [email protected] ...
Find out more about the different types of breathing patterns and respiration rates like dyspnea, bradypnea, tachypnea, and ... Dyspnea. This is when you feel "short of breath," like your body cant get enough air. Its a common symptom of many heart and ... Several types of dyspnea happen only when your body is in a certain position. They include:. *Orthopnea, when you feel short of ... Trepopnea is a kind of dyspnea that happens when you lie on a certain side. It might happen when you lie on your left side but ...
Paroxysmal nocturnal dyspnea (PND) causes sudden shortness of breath during sleep. Well tell you what causes it and how its ... Dyspnea can occur at any time of the day or night. Its a potential symptom of a number of serious respiratory and circulatory ... Paroxysmal nocturnal dyspnea vs. sleep apnea. PND is a symptom that can be caused by a number of different respiratory and ... COPD and Dyspnea. COPD damages your lungs and prevents them from working as they are designed. Learn exactly how COPD affects ...
Paroxysmal Nocturnal Dyspnoea. Br Med J 1965; 2 doi: https://doi.org/10.1136/bmj.2.5457.361-b (Published 07 August 1965) Cite ...
... , Causes of Dyspnea with Clear Lung Sounds. ... Dyspnea Causes. search Dyspnea Causes, Causes of Dyspnea with ... Chronic Dyspnea in Adults (Duration ,1 month). *Obstructive Lung Disease (COPD, Asthma) ... See Medication Causes of Dyspnea. * Metabolic Acidosis (with compensatory Tachypnea). *Includes Aspirin Overdose (Salicylate ...
Dyspnea, can originate from both chemical and mechanical receptors in the lungs, chest wall, muscles, brain, and face. Dyspnea ... Opioids are the medications of choice for treating dyspnea. Support groups, therapy, relaxation techniques, education, and even ... Dyspnea and dyspnea on exertion can severely impair a persons physical abilities to pursue activities of daily living and can ... About one-quarter of patients with advanced cancer experience dyspnea. Dyspnea is very common with pulmonary diseases that ...
... , MRC Dyspnea Index, mMRC Score, Medical Research Council Dyspnea Index, Modified Medical Research Council Dyspnea ... Dyspnea Index. Aka: Dyspnea Index, MRC Dyspnea Index, mMRC Score, Medical Research Council Dyspnea Index, Modified Medical ... Grade 3: Dyspnea limits walking pace (slower than others of same age) and stops to catch breath ... Grade 5: Dyspnea prevents leaving house and performing Activities of Daily Living ...
... ANSWER If you have shortness of breath, you often can build up your lung ... How is shortness of breath (dyspnea) treated?. NEXT QUESTION: What is watchful waiting for mild nontuberculous mycobacterial ...
... dyspnea, respectively. Increases from mild to severe dyspnea were significant at . indicates a significance level of . ... severe dyspnea versus mild dyspnea) served as covariate for the anticipation contrast (anticipation severe dyspnea versus ... Each load was followed by two Borg rating scales, one on dyspnea intensity and one on dyspnea unpleasantness. The order of the ... Activation during dyspnea anticipation and dyspnea perception showed substantial overlap within the parietal operculum and the ...
Paroxysmal atrial fibrillation, dyspnea. Ill make this quick and condense it in a nutshell. Just to let you know, Im a 23 ... My Cardiologist gave me this paper and it says "paroxysmal artial fibrillation and dyspnea." He also said I should take some ... My Cardiologist gave me this paper and it says "paroxysmal artial fibrillation and dyspnea." He also said I should take some ... So my question is, is paroxysmal Atrial Fibrillation and dyspnea dangerous? I also noticed that when Im standing up or walking ...
... who awaken suddenly at night feeling short of breath and gasping for air could be suffering from paroxysmal nocturnal dyspnea, ... Chapter 11 Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea. Clinical Methods: The History, Physical, and Laboratory ... What Is Paroxysmal Nocturnal Dyspnea?. By Michele Blacksberg RN HERWriter Average Select rating. Poor. Fair. Average. Good. ... Having had episodes of orthopnea or dyspnea with exertion. There are also non-cardiac reasons for PND. PND is a term that may ...
Causes of dyspnea (shortness of breath) include asthma, COPD, heart attack, pneumonia, COVID-19 and other issues. Rush experts ... Rush Excellence in Dyspnea Care. *An expert team, centered on you: If your dyspnea turns out to be related to a chronic health ... Treatment for Dyspnea at Rush. Because dyspnea has so many potential causes, your treatment plan will depend on whats causing ... Trouble Breathing (Dyspnea). Rush experts can find and treat the cause of your dyspnea (shortness of breath): asthma, COPD, ...
Dyspnea refers to the awareness of breathing discomfort that is typically experienced during exercise in health and disease. ... Dyspnea. Respiration Disorders. Respiratory Tract Diseases. Signs and Symptoms, Respiratory. Signs and Symptoms. Ondansetron. ... Sensory Intensity (Borg 0-10 scale) ratings of dyspnea at isotime [ Time Frame: Participants will be followed until all study ... In various participant populations, dyspnea is a predictor of disability and death; and contributes to exercise intolerance and ...
Dyspnea is a term used to characterize a subjective experience of breathing discomfort that is comprised of qualitatively ... On Dyspnea in Advanced Cancer, Southampton University, 1993.. *Dudgeon DJ, Lertzman M. Dyspnea in the advanced cancer patient. ... Language of dyspnea. In: Dyspnea; Mechanisms, measurement and management, 2nd, Mahler DA, ODonnell DE (Eds), Taylor & Francis ... An approach to the diagnosis of dyspnea in adults and the management of specific causes of dyspnea are addressed elsewhere as ...
Patients who complete dyspnea NRS on day 7 +/- 2 counted as successes. Dropouts defined as subjects who do not complete the ... Dyspnea. Difficulty breathing. Shortness of breath. Dexamethasone. Decadron. Placebo. Sugar pill. Questionnaires. Surveys. ... Completion Rate of Dyspnea Numeric Rating Scale (NRS) [ Time Frame: 7 days ]. Primary objective is to determine completion rate ... Dyspnea. Hematologic Diseases. Respiration Disorders. Respiratory Tract Diseases. Signs and Symptoms, Respiratory. Signs and ...
DyspneaClassifications and external resources ICD-10 R06.8 ICD-9 786.0 DiseasesDB 15892 MedlinePlus 003075 Dyspnea or Dyspnoea ... Dyspnea or Dyspnoea (Pronounced disp-nee-ah, from the Latin dyspnoea, Greek dyspnoia from dyspnoos, shortness of breath) or ... Dyspnea on exertion (DOE or exertional dyspnea) indicates dyspnea that occurs (or worsens) during physical activity. ... Paroxysmal nocturnal dyspnea References. Lippincott Williams & Wilkins (2006). Stedmans Medical Dictionary, 28th Edition. ...
... often called dyspnea, is labored, difficult breathing or shortness of breath that can occur at any time during the breathing ... Treatment of Dyspnea in Dogs. The treatment for dyspnea depends upon the underlying cause. Often, treatment is initiated to ... Overview of Dyspnea (Trouble Breathing) in Dogs. Respiratory distress, often called dyspnea, is labored, difficult breathing or ... Dyspnea (Trouble Breathing) in Dogs. 22 Jul, 2015 PetPlace.com Veterinarians 430,542 Views ...
  • One reason is our staff, which includes a board-certified pulmonologist and exercise physiologist who has specialized in dyspnea during exertion for over two decades. (massgeneral.org)
  • Dyspnea on Exertion' Everyone feels out of breath when they exercise hard enough, but lung and heart disease causes people to become short of breath at lower levels of exercise, when they walk, do household chores, or sometimes even when they dress themselves. (google.com)
  • Dyspnea on exertion is the shortness of breath that occurs with increasing activity. (heart.org)
  • Dyspnea and dyspnea on exertion can severely impair a person's physical abilities to pursue activities of daily living and can threaten a person's quality of life. (cancersupportivecare.com)
  • In a series of patients with advanced cancer, approximately 30 percent reported dyspnea and of these 70 percent reported episodic breathlessness, most often triggered by exertion [ 2 ]. (uptodate.com)
  • Dyspnea on exertion ( DOE or exertional dyspnea ) indicates dyspnea that occurs (or worsens) during physical activity. (bionity.com)
  • The board said Mr Sharif with past medical history of hypertension, T2 diabetes mellitus, ischemic heart disease and CABGH, kidney stone disease complained about post nasal drip, bilateral arm, shoulder pain and some dyspnoea on exertion. (thefreedictionary.com)
  • She has also complained of dyspnoea on moderate exertion. (thefreedictionary.com)
  • You may experience dyspnea at rest, or on exertion (when you perform any activity no matter how small), if you have certain conditions. (chemocare.com)
  • Dyspnea on mild exertion is indicative of left sided heart failure is usually accompanied by othermanifestations (orthopnea, paroxysmal nocturnal dyspnea). (doctorslounge.com)
  • The etiology of angina-associated dyspnea on exertion is a transient increase in left ventricular end-diastolic pressure secondary to ischemia, superimposed on reduced ventricular compliance. (uspharmacist.com)
  • 6 Pharmacists should note that, in the elderly, dyspnea on exertion is a more common manifestation of myocardial ischemia than is chest pain. (uspharmacist.com)
  • 6 Physical deconditioning can cause dyspnea only on exertion in patients with a sedentary lifestyle, while anemia can cause dyspnea on exertion progressing to dyspnea at rest. (uspharmacist.com)
  • 7 Patients with CHF and pulmonary vascular congestion may complain of dyspnea with exertion or even at rest, orthopnea (dyspnea that is relieved in the upright position), PND, and nocturia. (uspharmacist.com)
  • Reports on a 59-year-old woman with long-standing seropositive rheumatoid arthritis presented to the Mayo Clinic in Rochester, Minnesota, with symptoms of dyspnea on exertion that had worsened gradually. (ebscohost.com)
  • He describes worsening dyspnea on exertion that is associated with chest tightness, wheezing, and coughing. (medscape.com)
  • An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. (google.com)
  • Nevertheless, the effective management of dyspnea and activity-limitation remains an elusive goal for many healthcare providers and current strategies aimed at reversing the underlying chronic disease are only partially successful in this regard. (clinicaltrials.gov)
  • Because patients may first seek care by calling their physician's office, telephone triage plays a role in the early management of dyspnea. (aafp.org)
  • Controlled single-dose trials have suggested that opioids are effective in the management of dyspnea associated with chronic obstructive lung disease [4] . (annals.org)
  • Dyspnea is a symptom that may be accompanied by other symptoms, such as chest tightness, anxiety, and a feeling of suffocation. (diseaseinfosearch.org)
  • Shortness of breath (dyspnea) is a symptom, something the patient feels. (google.com)
  • It is maddeningly difficult to know if patients with heart failure stop exercising because they are short of breath or because they are limited for some other reason and incidentally report dyspnoea as an accompanying symptom. (medscape.com)
  • Understanding dyspnoea became more difficult when we tried to decipher the genesis of the symptom in patients with chronic heart failure. (medscape.com)
  • As pulmonary artery pressures rose, exercise tolerance worsened, but patients often noted that dyspnoea was no longer a troublesome symptom and that fatigue had become the primary symptom that limited activities of daily living. (medscape.com)
  • To articulate a new conceptual model of breathlessness - termed total dyspnoea - which translates the well recognized total pain model to the realm of dyspnoea and addresses the patient's experiences of this symptom in the physical, psychological, social, and spiritual domains. (nih.gov)
  • In the past year, studies in the field of dyspnoea have explored a host of new approaches spanning pharmacological, mechanical, and behavioral strategies for symptom management and resolution. (nih.gov)
  • This paper introduces total dyspnoea as a new paradigm that provides palliative care clinicians with an organizing structure for this complex symptom and body of evidence. (nih.gov)
  • Regardless of the ability to treat the underlying cause, the symptom of dyspnea can be alleviated through a variety of pharmacologic and non-pharmacologic means. (cancersupportivecare.com)
  • Dyspnea is the aversive and threatening cardinal symptom in prevalent diseases such as asthma and chronic obstructive pulmonary disease (COPD) and associated with great individual and socioeconomic burden [ 1 ]. (hindawi.com)
  • Dyspnea is a fairly common symptom that has many possible causes, including weight gain, heart attack , pneumonia , asthma , chronic obstructive pulmonary disease (COPD) or COVID-19 . (rush.edu)
  • To this end, the investigators will compare the effects of inhaled 0.9% saline placebo and inhaled ondansetron (8 mg) on detailed assessments of neural respiratory drive (diaphragm EMG), ventilation, breathing pattern, dynamic operating lung volumes, contractile respiratory muscle function, cardio-metabolic function and dyspnea (sensory intensity and affective responses) during symptom-limited, high-intensity, constant-work-rate cycle exercise testing in healthy, men aged 20-40 years. (clinicaltrials.gov)
  • Dyspnea is a multidimensional symptom, consisting of affective as well as physical aspects. (uptodate.com)
  • Dyspnea is a common symptom in patients presenting to the primary care office. (aafp.org)
  • Acute dyspnea is shortness of breath that lasts between hours to days and is always an alarm symptom that requires prompt attention. (doctorslounge.com)
  • Dyspnea is not only a symptom of severe or chronic pulmonary disease, but is also associated with a wide variety of pulmonary, cardiac, and other causes. (uspharmacist.com)
  • Dyspnea is an aversive symptom in various diseases. (nih.gov)
  • See detailed information below for a list of 14 causes of Fatigue with dyspnea , Symptom Checker , including diseases and drug side effect causes. (rightdiagnosis.com)
  • A 49 year-old physically active woman developed recurrent symptom-limiting exertional dyspnea and chest pain while attempting to complete her usual 4-mile daily jog. (massgeneral.org)
  • The following list of conditions have ' Fever with dyspnea ' or similar listed as a symptom in our database. (rightdiagnosis.com)
  • Refractory dyspnea is a common and distressing symptom complicating respiratory illness, including chronic obstructive pulmonary disease, and life-limiting illnesses in general, including cancer. (ovid.com)
  • Chapter 11 Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea. (empowher.com)
  • Paroxysmal nocturnal dyspnea is an intense form of orthopnea. (howstuffworks.com)
  • Orthopnea: dyspnea on lying flat. (doctorslounge.com)
  • 9 Clinically, patients with hypothyroid cardiomyopathy, a condition that can lead to heart failure, are somewhat unusual in that they are likely to experience dyspnea without orthopnea. (uspharmacist.com)
  • Our thinking about dyspnoea in heart failure has long been heavily influenced by observations in patients with acute heart failure, particularly those who present with acute pulmonary oedema. (medscape.com)
  • [ 3 ] Interestingly, when bedside cardiology was in its heyday, the most reliable objective finding that presaged the relief of dyspnoea in patients with acute pulmonary oedema was not measures of respiratory rate, blood oxygenation, or pulmonary function, but rather the cessation of diaphoresis. (medscape.com)
  • Acute dyspnea in the office. (gpnotebook.co.uk)
  • Dyspnea may be acute, developing over a matter of hours, or chronic, growing in severity gradually over weeks or months. (cornell.edu)
  • Acute dyspnoea secondary to diaphragmatic paralysis can also occur following minor cervical trauma. (thefreedictionary.com)
  • Explain to interested patients that BNP testing to determine the presence of congestive heart failure in acute dyspnea was limited to patients arriving at an emergency department and could not be generalized to private practice. (medpagetoday.com)
  • BASEL, Switzerland, May 23 - B-type natriuretic peptide (BNP) testing for congestive heart failure paid for itself with more effective clinical management of patients arriving at the ER with acute dyspnea, according to a study. (medpagetoday.com)
  • To estimate the long-term cost effectiveness of BNP guidance, the researchers conducted a prospective randomized study (B-Type Natriuretic Peptide for Acute Shortness of Breath Evaluation), including 452 patients (mean age 71) who came to the emergency department with acute dyspnea. (medpagetoday.com)
  • Measuring BNP directly at presentation in all patients with acute dyspnea seems to be a reasonable strategy," Dr. Mueller said. (medpagetoday.com)
  • Family physicians should be prepared and equipped to triage, manage, and stabilize patients with acute dyspnea. (aafp.org)
  • Telephone triage of acute dyspnea in the physician's office. (aafp.org)
  • The underlying causes of dyspnea are classified as acute causes and chronic causes based on the disease course. (wikidoc.org)
  • The following algorithm helps narrow down the causes for acute dyspnea. (doctorslounge.com)
  • Diagnosis and management of patients presenting with acute dyspnea is one of the major challenges for physicians in emergency department (ED). A correct diagnosis is frequently delayed and difficult to ascertain, and clinical uncertainty is common, explaining the need for rapid diagnosis and a management plan. (nih.gov)
  • The primary aim of our study is to assess a diagnostic strategy using multiorgan point of care ultrasonography (USG) to differentiate patients presenting with acute dyspnea to ED into different diagnostic categories for timely management in a resource-limited setting. (nih.gov)
  • In addition, dyspnea can result from fluid filling the air spaces in the lungs (as with pulmonary edema from Congestive Heart Failure or fluid overload). (cancersupportivecare.com)
  • Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. (ahajournals.org)
  • Cough, pain and dyspnoea: similarities and differences. (google.com)
  • An approach to the diagnosis of dyspnea in adults and the management of specific causes of dyspnea are addressed elsewhere as are the management of advanced lung disease, cough, stridor, and hemoptysis in palliative care populations. (uptodate.com)
  • Animals showing clinical signs like chronic cough, dyspnoea , exercise intolerance, abdominal distension, syncope and cyanosis were selected and subjected to ECG and echocardiographic examination to confirm the diagnosis. (thefreedictionary.com)
  • Symptoms of radiation-induced lung injury can include cough and dyspnoea , with the more extreme lung fibrosis requiring oxygenation and assisted ventilation [9]. (thefreedictionary.com)
  • With some causes of dyspnea, such as chronic bronchitis, and pulmonary fibrosis, severe outbreaks of cough, shortness of breath and congestion (called exacerbations), may last for a few months at a time, and occur a few times a year. (chemocare.com)
  • Symptoms such as dyspnea or cough may indicate pneumonitis. (ons.org)
  • Cough + wheezing: asthma (episodic dyspnea). (doctorslounge.com)
  • Case 12-2020: A 24-Year-Old Man with Fever, Cough, and Dyspnea. (harvard.edu)
  • A 53-year-old man comes in with a cough, chest pain, and dyspnea that he's had for several weeks. (cancernetwork.com)
  • The presentation was so dramatic that it seemed reasonable to surmise that oxygen transport was impaired, and that the resulting hypoxaemia was responsible for the sensation of dyspnoea. (medscape.com)
  • Dyspnea is a subjective sensation of difficulty breathing. (cancersupportivecare.com)
  • As dyspnea is a subjective sensation, it must be identified by the person him or herself and there is no test that can definitely identify dyspnea. (cancersupportivecare.com)
  • Bronchial obstruction and dyspnea: detection, perception, sensation]. (nih.gov)
  • Dyspnea is also the uncomfortable sensation of breathing. (chemocare.com)
  • Dyspnea is a subjective experience of difficult breathing or sensation of breathlessness that can occur rapidly and lead to a feeling of impending doom. (ons.org)
  • Although dyspnea is a relatively common problem, the pathophysiology of the uncomfortable sensation of breathing is poorly understood. (merckmanuals.com)
  • Dyspnea is defined as an uncomfortable sensation of breathing in varying intensity. (omicsonline.org)
  • The sensation of dyspnea may be developed by any or combination of the sense of respiratory effort, chemoreceptor stimulation, mechanical stimuli arising in lung and chest wall receptors and neuroventilatory dissociation. (omicsonline.org)
  • The sensation of dyspnea appears closely related to respiratory muscle function. (ahajournals.org)
  • 1 By factor analysis, multiple domains of disease entities involve dyspnea, psychological status, health-related quality of life, and sensation or perception of dyspnea, 2 wherein dyspnea is commonly evaluated by dyspnea scales such as Medical Research Council (MRC), Baseline Dyspnea Index, Oxygen-Cost Diagram, St George Respiratory Questionnaire activity domain, and Chronic Respiratory Disease Questionnaire dyspnea domain (CRQ-dyspnea). (dovepress.com)
  • Rush experts can find and treat the cause of your dyspnea (shortness of breath): asthma, COPD, heart attack, pneumonia, COVID-19 or other issues. (rush.edu)
  • 1 More than 56% of patients with advanced chronic obstructive pulmonary disease (COPD) and 70% of individuals with advanced cancer report moderate-to-severe dyspnea. (uspharmacist.com)
  • According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, either a modified Medical Research Council (mMRC) dyspnea score of ≥2 or a chronic obstructive pulmonary disease (COPD) assessment test (CAT) score of ≥10 is considered to represent COPD patients who are more symptomatic. (dovepress.com)
  • Assessments were made using the Modified Medical Research Council (mMRC) dyspnea scale or the COPD Assessment Test to distinguish between patients with low or high symptoms. (ajmc.com)
  • The authors said the analysis confirmed that patients with COPD with more severe dyspnea at baseline, measured using the mMRC scale, had a greater response to tiotropium/olodaterol relative to tiotropium alone in both SGRQ total score and SGRQ responder rate. (ajmc.com)
  • The proposed study will be the first to systematically test the hypothesis that pathophysiological abnormalities in ventilatory demand, pulmonary gas exchange, small airway function, dynamic ventilatory mechanics and respiratory muscle function contribute significantly to exertional dyspnea and activity-limitation in patients with mild COPD. (bioportfolio.com)
  • Dyspnea intensity rises in COPD during exercise in tandem with inspiratory neural drive (IND), measured by diaphragm activation. (ersjournals.com)
  • We examined dyspnea intensity, IND (EMGdi/EMGdi,max), ventilation, and operating lung volumes, during randomized 4 min constant work rate exercise tests (75% peak work rate) in patients with severe COPD (n=13). (ersjournals.com)
  • The strong relationship between dyspnea intensity and diaphragm activation during exercise in COPD was not altered by selective therapeutic manipulation of central medullary or cortical motor centers which introduced significant differences in ventilation, and resting and dynamic respiratory mechanics. (ersjournals.com)
  • Limitation in the lungs' ability to move air (as with Asthma) or restriction in its ability to expand (as with pneumothorax or scarring from radiotherapy) also can create dyspnea. (cancersupportivecare.com)
  • Paroxysmal nocturnal dyspnea is also sometimes called cardiac asthma because its signs and symptoms mimic those of asthma. (howstuffworks.com)
  • While asthma is a chronic condition caused by inflammation of the airways, which can lead to breathing difficulties, paroxysmal nocturnal dyspnea is a sign of heart failure. (howstuffworks.com)
  • Asthma-induced dyspnea, on the other hand, can affect cats of all ages, but it may occur with increased frequency in warm weather, "when flowers are blooming," notes Dr. Fletcher, "and there's lots of pollen in the air. (cornell.edu)
  • In dyspnoea due to emphysema, phthisis and asthma, strychnine is of service, given internally in doses of i to 3 minims of the liquor. (yourdictionary.com)
  • Dyspnea associated with obstructive lung diseases such as asthma or chronic bronchitis. (thefreedictionary.com)
  • Similarly, infection in the air space (pneumonia) creates dyspnea. (cancersupportivecare.com)
  • If your bronchitis, pneumonia or other cause of dyspnea are due to a virus, your symptoms may take 2 or more weeks to resolve, but antibiotics won't help. (chemocare.com)
  • Common Causes of dyspnea include anemia , foreign body aspiration , heart failure , pneumonia , pregnancy , and pulmonary edema . (wikidoc.org)
  • For patients experiencing unexplained shortness of breath, or dyspnea, the specialists at University Hospitals Harrington Heart & Vascular Institute offer advanced testing capabilities to help diagnose the underlying condition or cause of the breathlessness. (uhhospitals.org)
  • Many patients with breathlessness have both cardiovascular and pulmonary diseases that require treatment, so the Dyspnea Center provides expanded diagnostic testing to measure both heart and lung function in patients. (uhhospitals.org)
  • Designed as a regional resource for evaluation and management of breathlessness, the Dyspnea Center offers expertise in the latest noninvasive and invasive cardiopulmonary exercise techniques to help determine the cause of symptoms and enhance patient care. (uhhospitals.org)
  • Dyspnea" is a medical term that refers to shortness of breath, breathlessness, or uncomfortable breathing. (healthline.com)
  • Dyspnea is a feeling of breathlessness. (cancer.net)
  • Dyspnea is a condition where you are experiencing shortness of breath, or breathlessness. (chemocare.com)
  • However, dyspnea is a subjective experience of breathlessness, and patients describe it as they experience it ( TABLE 1 ), with variations depending on its cause. (uspharmacist.com)
  • Dyspnea catastrophizing and general trait anxiety were measured with the Breathlessness Catastrophizing Scale (BCS) and the State-Trait Anxiety Inventory, respectively. (nih.gov)
  • Finding the right clinical trial for Dyspnea can be challenging. (diseaseinfosearch.org)
  • To avoid further fragmentation in clinical approaches to dyspnoea, healthcare providers need to view recent findings within the context of a coherent framework, one that places newly demonstrated interventions in the broader context of the full patient experience. (nih.gov)
  • In addition to obvious difficulty in breathing in and out, cats exhibiting dyspnea frequently show a variety of associated clinical signs. (cornell.edu)
  • Because dyspnea is a clinical sign and not a diagnosis," Dr. Fletcher points out, "its progression will depend on the specific disease process that is causing the problem. (cornell.edu)
  • Angina pectoris is a clinical syndrome of coronary artery disease that is caused by myocardial ischemia and characterized by dyspnea and precordial discomfort, pressure, or pain. (uspharmacist.com)
  • Clinical introduction A 60-year-old man had a long history of chronic hepatitis C. He presented to the emergency department with 2 days of progressive dyspnoea. (bmj.com)
  • The present study concludes that integrating focused multiorgan USG by lung-cardiac-IVC and renal ultrasound into routine clinical evaluation of patients with dyspnea has a higher accuracy for differentiating causes of dyspnea in emergency department. (nih.gov)
  • Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. (google.com)
  • Dyspnea is very common with pulmonary diseases that impact the lungs' ability to exchange oxygen (for example, Chronic Obstructive Pulmonary Disease, Lung Cancer, and lung metastases). (cancersupportivecare.com)
  • Several recent systematic reviews, two focusing on people with chronic obstructive pulmonary disease and the other focusing on people with cancer, strengthen the evidence base behind the use of palliative oxygen for relief of refractory dyspnea, and support the observation that there are subgroups of people who benefit from oxygen, such as individuals with chronic obstructive pulmonary disease. (ovid.com)
  • American Thoracic Society Committee on Dyspnea. (google.com)
  • Case Image: Successful endovascular treatment of a giant left subclavian artery pseudoaneurysm causing severe dyspnea. (diseaseinfosearch.org)
  • Case 4 - A 59-Year-Old Woman with Rheumatic Mitral Valve Disease (Severe Stenosis and Regurgitation), Severe Dyspnea, Shock and Pulmonary Condensation. (diseaseinfosearch.org)
  • Severe dyspnea activated a network of sensorimotor, cerebellar, and limbic areas. (hindawi.com)
  • Left insular and parietal opercular cortex showed increased connectivity with right insular and anterior cingulate cortex when severe dyspnea was anticipated, while the cerebellum showed increased connectivity with the amygdala. (hindawi.com)
  • A new study looking at whether baseline symptomatic status influences response to treatment suggests that patients with more severe dyspnea benefit more from a combination of tiotropium/olodaterol than tiotropium alone. (ajmc.com)
  • According to the American Thoracic Society, dyspnea is a term used to "characterize a subjective experience of breathing discomfort that comprises qualitatively distinct sensations that vary in intensity. (springer.com)
  • Shortness of breath or dyspnoea is a subjective phenomenon where a person feels like running out of air and of not being able to breathe fast or deeply enough (1). (gpnotebook.co.uk)
  • In a consensus statement, 2 the American Thoracic Society defined dyspnea as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity. (aafp.org)
  • Dyspnea is a subjective phenomenon based on the variation in severity for a given degree of functional impairment. (aafp.org)
  • He returned 18 days later with severe dyspnoea, subjective fever and bilateral lower extremity oedema. (bmj.com)
  • Owing to its subjective nature, as with pain, dyspnea is an experience influenced by both physiological and psychological factors. (uspharmacist.com)
  • Shortness of breath, or dyspnea, is a common problem in the outpatient primary care setting. (aafp.org)
  • The Massachusetts General Hospital Dyspnea Clinic is staffed by world-class specialists who evaluate and treat patients with unexplained dyspnea (shortness of breath), including the most complicated cases. (massgeneral.org)
  • This according to a study that included consecutive patients with unexplained dyspnea referred for invasive hemodynamic exercise testing. (mdedge.com)
  • Notably, the perception of dyspnea is not tightly related to objective lung function [ 2 ] but is modulated by cognitive and affective factors [ 3 - 6 ]. (hindawi.com)
  • Studies have shown that the type and severity of an underlying lung or heart disease correlates well with the way the patient describes the dyspnea. (aafp.org)
  • Prevalence of dyspnea has been reported to be highest in patients with lung, breast, and esophageal cancer. (ons.org)
  • In patients with mMRC scores of 0 to 1 and 2 or greater, tiotropium/olodaterol consistently improved transition dyspnea index response rate and lung function versus placebo and tiotropium. (ajmc.com)
  • Dyspnoea will worsen due to restriction of lung and chest expansion. (bmj.com)
  • Dyspnea is the feeling of shortness of breath or difficulty breathing. (diseaseinfosearch.org)
  • Dyspnea or Dyspnoea (Pronounced disp-nee-ah , from the Latin dyspnoea , Greek dyspnoia from dyspnoos , shortness of breath) or shortness of breath ( SOB ) is perceived difficulty breathing or painful breathing . (bionity.com)
  • Paroxysmal' means 'sudden attacks that recur,' 'nocturnal' means 'occurring at night' and 'dyspnea' means 'difficulty breathing' or 'shortness of breath. (howstuffworks.com)
  • Fayomi, who works with a Private Hospital in Gwagalada, told the News Agency of Nigeria (NAN) on Thursday in Abuja that difficulty with breathing was also called dyspnoea in medical terms. (thefreedictionary.com)
  • Fatigue with dyspnea is a condition in which there is excessive tiredness or weariness coupled with difficulty breathing. (rightdiagnosis.com)
  • If you have difficulty catching your breath, feel intense tightening in your chest, or feel like you're suffocating, you are suffering from dyspnea-also called shortness of breath. (utah.edu)
  • Dyspnea ( Latin dyspnoea , Greek dyspnoia from dyspnoos - short of breath) or shortness of breath ( SOB ) is perceived difficulty breathing or pain on breathing. (academickids.com)
  • Dyspnea, which means difficulty breathing , occurs when a pet is having the feeling of shortness of breath. (pethealthnetwork.com)
  • Paroxysmal nocturnal dyspnea or paroxysmal nocturnal dyspnoea (PND) is an attack of severe shortness of breath and coughing that generally occurs at night. (wikipedia.org)
  • UpToDate: "Patient education: Shortness of breath (dyspnea) (Beyond the Basics). (webmd.com)
  • Once the patient is in the office, the initial goal of assessment is to determine the severity of the dyspnea with respect to the need for oxygenation and intubation. (aafp.org)
  • In a stable patient, management depends on the underlying etiology of the dyspnea. (aafp.org)
  • 1 Dyspnea can be extremely distressing not only for the patient, but for many families and caregivers alike who witness an episode. (uspharmacist.com)
  • Dyspnea is unpleasant or uncomfortable breathing. (merckmanuals.com)
  • Dyspnea has been defined as an uncomfortable awareness of breathing [1] . (annals.org)
  • This syndrome is characterized by abrupt and marked increases in cardiac filling and pulmonary venous pressures, which are accompanied by overwhelming dyspnoea at rest. (medscape.com)
  • Subsequent efforts to understand dyspnoea relied on cardiopulmonary exercise testing with simultaneous measurements of gas exchange and invasive assessments of cardiac pressures and blood flows. (medscape.com)
  • [ 6 , 7 ] Instead, the studies suggested a role for a low cardiac output as a mechanism for dyspnoea, based on the belief that a decrease in cardiac output (leading to poor pulmonary perfusion and ventilation-perfusion mismatching) might cause exercise-induced tachypnoea. (medscape.com)
  • Two types of dyspnea are significant in cardiac illness. (heart.org)
  • People who awaken suddenly at night feeling short of breath and gasping for air could be suffering from paroxysmal nocturnal dyspnea, particularly if they have cardiac disease. (empowher.com)
  • Dyspnea is most commonly caused by respiratory and cardiac disorders. (aafp.org)
  • The H 2 FPEF score enables discrimination of heart failure with preserved ejection fraction (HFpEF) from non-cardiac causes of dyspnea and can assist in determination of the need for further diagnostic testing in the evaluation of patients with unexplained exertional dyspnea. (mdedge.com)
  • Diagnosis of HFpEF (case) or non-cardiac dyspnea (control) was determined by invasive hemodynamic exercise testing. (mdedge.com)
  • 3 Dyspnea is also one of the most common symptoms reported by patients receiving palliative care. (uspharmacist.com)
  • Does Dyspnea Really Matter in Heart Failure? (medscape.com)
  • Questioning the Obvious: Does Dyspnoea Really Matter in Heart Failure? (medscape.com)
  • Dyspnoea is the cardinal manifestation of heart failure and remains its most perplexing feature. (medscape.com)
  • Those afflicted with chronic heart failure typically report both symptoms of dyspnoea and exercise intolerance, but does dyspnoea actually limit activities of daily living? (medscape.com)
  • Although it may seem obvious that dyspnoea impairs quality of life in heart failure, it is time to question the obvious. (medscape.com)
  • Studies of patients with chronic heart failure and left ventricular systolic dysfunction concluded that pulmonary venous congestion was not a critical factor in the genesis of dyspnoea. (medscape.com)
  • If your dyspnea turns out to be related to a chronic health problem like heart failure or allergies, your pulmonologist will refer you to Rush specialists who can help treat the underlying condition. (rush.edu)
  • and chronic dyspnea occurs within hours to years-examples include pleural effusion, heart failure, anemia, and physical deconditioning. (uspharmacist.com)
  • Dyspnea is one of the symptoms of heart disease, specifically heart failure or a heart attack. (utah.edu)
  • BACKGROUND Patients with heart failure (HF) frequently experience exertional dyspnea. (ahajournals.org)
  • Dyspnea is a condition that causes difficult or labored breathing, often caused by heart conditions. (heart.org)
  • Establishing a diagnosis can be challenging because dyspnea appears in multiple diagnostic categories. (aafp.org)
  • Dyspnea has been estimated to occur in 15%-55% of patients at the time of cancer diagnosis and as many as 70% of patients with terminal cancer. (ons.org)
  • Concordance between ED diagnosis of dyspnea using the diagnostic strategy proposed in the study with final hospital diagnosis was high with agreement in 88% of patients (Kappa statistic = .805, p = .000) which is statistically significant. (nih.gov)
  • AbstractBackgroundThe complexity of diagnosis for critically ill dyspnea presentations in the emergency department remains a challenge. (medworm.com)
  • Point-of-care ultrasound (POCUS) has been shown to impact the diagnosis of dyspnea presentations in resource-rich settings, and may be of greater diagnostic benefit in resource-limited settings.MethodsWe prospectively enrolled a convenience sample of 100 patients presenting with dyspnea in the Emergency Department at University Teaching Hospital of Kigali (UTH-K) in Rwanda. (medworm.com)
  • Two treatment approaches to dyspnea associated with malignant pleural effusions appeared to be similar in a randomized trial. (medpagetoday.com)
  • The first symptoms are those associated with worsening dyspnoea, pleural effusions, chest pain, and weight loss. (bmj.com)
  • Etiology, assessment, and treatment of dyspnea at the end of life. (capc.org)
  • Dyspnea cases clearly due to neither cardiogenic nor respiratory etiology will considered not eligible. (knowcancer.com)
  • Several types of dyspnea happen only when your body is in a certain position. (webmd.com)
  • The treatment for dyspnea depends upon the underlying cause. (petplace.com)
  • Optimal treatment for dyspnea requires a combination of home and professional veterinary care. (petplace.com)
  • It is likely that the experience of dyspnea results from a complex interaction between chemoreceptor stimulation, mechanical abnormalities in breathing, and the perception of those abnormalities by the central nervous system (CNS). (uspharmacist.com)
  • The experience of dyspnea likely results from a complex interaction between chemoreceptor stimulation, mechanical abnormalities in breathing, and the perception of those abnormalities by the CNS. (merckmanuals.com)
  • In particular the fearful anticipation of dyspnea has been hypothesized to lead up to this spiral of decline [ 20 ]. (hindawi.com)
  • Indeed, recent studies demonstrated that the anticipation of dyspnea is associated with increased physiological fear responses [ 21 ], especially in anxious individuals [ 22 ]. (hindawi.com)
  • Although the fearful anticipation of dyspnea might play a fundamental role for disease progression the underlying brain processes have rarely been studied. (hindawi.com)
  • However, during the anticipation of dyspnea, BCS scores correlated positively with activations of the anterior cingulate cortex (ACC), even after controlling for general anxiety levels. (nih.gov)
  • Rush offers state-of-the-art pulmonary function testing, including a full cardiopulmonary exercise lab that helps zero in on the causes of dyspnea associated with physical activity. (rush.edu)
  • In approximately two thirds of patients presenting with dyspnea, the underlying cause is cardiopulmonary disease. (aafp.org)
  • Cardiopulmonary exercise testing should be considered when there is no apparent cause for dyspnea after a thorough diagnostic evaluation. (aafp.org)
  • Dyspnea appeared to result from increased work of breathing, in part from hyperventilation and in part from increased resistance to air flow. (annals.org)
  • Blocks of severe and mild dyspnea alternated, each preceded by anticipation periods. (hindawi.com)
  • Anyone can experience mild dyspnea once in a while. (rush.edu)
  • Loads inducing either severe or mild dyspnea (dyspnea conditions) were presented in alternating order, with each condition being visually cued (anticipation conditions). (nih.gov)
  • Psycho-diagnostic variables in dyspnea. (umn.edu)
  • Home / Test Division / Reference Database / 1970 to 1979 / 1973 / Psycho-diagnostic variables in dyspnea. (umn.edu)
  • Dyspnea may be caused by physical factors, such as an airway obstruction, or biological factors, such as a decreased amount of red blood cells in the body. (diseaseinfosearch.org)
  • Dyspnoea and perception of airway obstruction]. (nih.gov)
  • When we determine a patient's dyspnea is caused by a pulmonary disorder, we develop the patient's personalized treatment plan and manage his or her follow-up care. (massgeneral.org)
  • The patient's dyspnea has worsened to the point that he can hardly walk from his couch to the bathroom without becoming extremely short of breath. (medscape.com)
  • Notably, insular activation during dyspnea perception was positively correlated with midbrain activation during anticipation. (hindawi.com)
  • The results demonstrate that dyspnea anticipation activates brain areas involved in dyspnea perception. (hindawi.com)
  • In chronic respiratory conditions the adequate perception of dyspnea plays a key role as it has a strong influence on health behavior and course of disease. (hindawi.com)
  • Notably, recent studies have demonstrated that negative emotions are related not only to increased perception but also to changes in the neural processing of dyspnea [ 18 ]. (hindawi.com)
  • The purpose of this study is to test the hypothesis that single-dose inhalation of nebulized ondansetron (a serotonin 5-HT3 receptor antagonist) will improve the perception of dyspnea during strenuous exercise in health, young men. (clinicaltrials.gov)
  • Unlike those for other types of noxious stimuli, there are no specialized dyspnea receptors (although recent MRI studies have identified a few specific areas in the midbrain that may mediate perception of dyspnea). (merckmanuals.com)
  • Recently, more dyspnea-specific forms of negative affectivity such as dyspnea catastrophizing were suggested to contribute to increased perception of dyspnea beyond effects of rather unspecific negative affectivity such as general anxiety levels. (nih.gov)
  • Therefore, the present retrospective analysis examined the associations of dyspnea catastrophizing with neural activations during the anticipation and perception of dyspnea. (nih.gov)
  • Correlating the BCS scores with neural activations during the perception of dyspnea yielded no significant results. (nih.gov)
  • Unexplained dyspnea, also known as shortness of breath, affects people of all ages and lifestyles while at rest and/or during exercise. (massgeneral.org)
  • When your physician has been unable to diagnose the reason for your dyspnea during exercise, it may be appropriate for you to be seen at the Dyspnea Clinic. (massgeneral.org)
  • Deconditioning and muscle weakness or fatigue may create dyspnea due to impacts on both the lungs and the heart and are likely under-appreciated in the assessment of shortness of breath and poor exercise tolerance. (cancersupportivecare.com)
  • Dyspnea' refers to the awareness of breathing discomfort that is typically experienced during exercise in health and disease. (clinicaltrials.gov)
  • It follows that alleviating dyspnea and improving exercise tolerance are among the principal goals of disease management. (clinicaltrials.gov)
  • However, dyspnea can also be caused by high-intensity exercise, very hot or cold temperatures, obesity, or high altitude. (utah.edu)
  • Pdi, time in inspiration (Ti), time per breath (TTOT), respiratory gases, ratings of perceived dyspnea and fatigue, and 760-800 nm near-infrared spectroscopy absorbency changes of the serratus anterior muscle were measured throughout exercise. (ahajournals.org)
  • A group of 10 patients who complained of exertional dyspnea largely after exercise and who had normal physical examination and chest roentgenograms is described. (annals.org)
  • We postulated that selective manipulation of central chemical and inspiratory muscle afferent inputs (by oxygen/opiates and bronchodilator, respectively) would not alter the fundamental relationship between dyspnea and IND during a standardized exercise task. (ersjournals.com)
  • The objectives of this study were to examine the relationships between exercise parameters and dyspnea in obesity and assess the effects of weight loss. (clinicaltrials.gov)
  • The investigators compared pulmonary function, exercise performance and dyspnea in 34 patients with abdominal obesity and metabolic syndrome (MS) against 34 age and sex-matched controls. (clinicaltrials.gov)
  • Pulmonary function, exercise performance and dyspnea results for normal weight controls were compared against the results for obese subjects. (clinicaltrials.gov)
  • Despite the feeling of suffocation, dyspnea does not cause suffocation or death, and patients may experience dyspnea even with normal oxygen levels. (diseaseinfosearch.org)
  • In the dyspnoea of advanced valvular disease of the heart morphine relieves the distress and restlessness, and induces sleep. (yourdictionary.com)